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In the review period, 97 new representatives of Stemona alkaloids were described, bringing the total
reported so far to 139. In this review, we discuss their isolation, structural elucidation, structural
classification, biological activities, semi-synthesis and total syntheses. These alkaloids are classified into
seven groups displaying either a pyrrolo[1,2-a]azepine or a pyrido[1,2-a]azepine core, and
a miscellaneous group comprising those alkaloids without these structural motifs, together with those






















8 References and notes1 Introduction
Herbal extracts from plants belonging to the Stemonaceae family
have been used in folk medicine in East Asia for thousands of
years, with three species of the Stemona genus (S. tuberosa,
S. japonica and S. sessilifolia) being listed in the 2000 edition of
the Chinese Pharmacopoeia as antitussive medicinal herbs.1 In
fact, the dried roots of the aforementioned species known as ‘Bai
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1908 | Nat. Prod. Rep., 2010, 27, 1908–1937‘Non Tai Yak’ or ‘Pong Mot Ngam’ in Thailand, are used to
suppress coughing, and are claimed to have antituberculosis,
antibacterial, antifungal and antihelmintic properties. However,
because of the similarity of the fleshy tuberous roots, the same
vernacular names are often used for different species, and even
for representatives of other plant families. Caution therefore is
needed in order to properly classify plant material for studies or
practical applications.2
The Stemona alkaloids display unique structures which have
sparked interest in their chemical and biological properties –
most of them have a pyrrolo[1,2-a]azepine or a pyrido[1,2-
a]azepine nucleus. A limited number of Stemona alkaloids either
lack (or have a hidden) pyrrolo[1,2-a]azepine core, which, in
some cases, can be revealed upon cleavage or formation of C–C
bonds.
This subject has been reviewed by G€otz & Strunz,3 Pilli & de
Oliveira4 (covering the literature from 1975 to 1998), Pilli, Rosso
& de Oliveira5 (covering the literature up to 2004), and Greger.6
Additionally, the synthetic approaches to Stemona alkaloids
were reviewed in 2004.7
In this review we provide an update on progress in the isola-
tion, structural elucidation, structural classification, biological
activities and total syntheses of 97 new representatives of the
Stemona alkaloids which have been described in the literature
since our first review article on this topic.42 Structural classification
The Stemona alkaloids are structurally characterized by the
presence of either an exposed or a hidden pyrrolo[1,2-a]azepine
(Fig. 1, n ¼ 1) or a pyrido[1,2-a]azepine core (Fig. 1, n ¼ 2) and
currently comprises 139 alkaloids, with 97 being reported after
our first review on this topic, when we suggested that they be
classified into five groups displaying the pyrrolo[1,2-a]azepine
nucleus and a miscellaneous group lacking this structural
motif.4
Recently, Greger has suggested a new classification based on
biosynthetic considerations, and has classified the Stemona alka-
loids into three skeletal types – the stichoneurine-type (tuber-




























































View Article Onlinealkaloids – differing by the carbon chains attached to C-9 of the
pyrrolo[1,2-a]azepine nucleus.6
Due to the emergence of new representatives, we now
suggest to organize them into eight groups (Fig. 1): stenine (I),
stemoamide (II), tuberostemospironine (III), stemonamine
(IV), parvistemoline (V), stemofoline (VI) (all of which contain
the pyrrolo[1,2-a]azepine core characteristic of the majority of
the Stemona alkaloids), stemocurtisine (VII) displaying the
pyrido[1,2-a]azepine nucleus, and a miscellaneous group
formed by those alkaloids which do not display the structural
motifs mentioned before, or are the sole representative of
a new group.Fig. 1 Stemona alkaloid groups.
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The number of Stemona alkaloids structurally related to stenine (1)
has grown to 21, with the addition of another 13 new structures
since our first report4 (Fig. 2): 2-oxostenine (2), isostenine (3),
sessilifoline B (4), tuberostemonine J (5), tuberostemonine H (6),
tuberostemonine N (7), tuberostemonine K (8), neo-
tuberostemonol (9), epi-bisdehydroneotuberostemonine J (10),
9a-bisdehydrotuberostemonine (11), 9a-bisdehydrotuber-
ostemonine A (12), tridehydrotuberostemonine (13) and sessili-
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View Article Online2-Oxostenine (2) was isolated from the roots of S. sessilifolia8
and S. mairei,9 but a full description of its physical data has not
been provided.
Isostenine (3) was obtained from the roots of S. collinsae, and
it was shown by 1H- and 13C-NMR data to display proton and
carbon connectivities similar to stenine (1)4 but a different
melting point and specific optical rotation. NOESY and NOE
difference experiments led the authors to propose isostenine (3)
to be a stereoisomer of stenine (1), having the same stereo-
structure except for H-1, H-11 and H-12.10 An alkaloid isolated
from S. tuberosa in a bioactivity-directed study was named
neostenine, and the same structure as isostenine (3) was
proposed.1 Although the authors claim to have established the
absolute configuration of the alkaloid isolated from the roots of
S. tuberosa1 by X-ray crystallography, significant differences in
the physical data of these two alkaloids can be found. The
structure proposed for neostenine has been confirmed by the
total syntheses described by Aube and coworkers and Booker-
Milburn and coworkers (Section 5.1).
Sessilifoline B (4) was isolated from the stems of S. sessilifolia,
and it was shown by 1D- and 2D-NMR experiments to have the
same stereostructure as stenine (1),4 except for the methyl group
at C-13 which is a-oriented in sessilifoline B (4).11
The structure of tuberostemonine J (5) and tuberostemonine H
(6), found in the roots of S. tuberosa, were assigned by spectro-
scopic analyses and their absolute configurations were claimed
based on X-ray crystallography data.1 They both differ from
tuberostemonine in the absolute configuration at C-1, C-9a, C-11
and C-12. Additionally, H-9 is a-oriented in tuberostemonine J
(5) while the corresponding hydrogens in tuberostemonine and
tuberostemonine H (6) are b-oriented.
Tuberostemonine N (7) was isolated from the underground
parts of S. tuberosa (HG 978) and its relative configuration was
established based on spectral data (including 1D- and 2D-NMR1910 | Nat. Prod. Rep., 2010, 27, 1908–1937experiments) which eventually led to the proposition of tuber-
ostemonine N (7) as the C-13 epimer of tuberostemonine.4,12
Tuberostemonine K (8), found in the root tubers of S. tuberosa,
was shown by 1D- and 2D-NMR studies to possess a two-
dimensional structure that closely resembles that of tuber-
ostemonine.4 The relative configuration of tuberostemonine K
(8) was assigned by a ROESY experiment, and it differs from
tuberostemonine by the H-11/H-12 a orientation (C/D ring
fusion) in tuberostemonine K (8).13
Neotuberostemonol (9) was isolated from herbal sample of S.
tuberosa and had its relative configuration unambiguously
established by X-ray crystallography in combination with spec-
troscopic data. Its absolute configuration was inferred from the
known configuration of tuberostemonine.4 Neotuberostemonol
(9) differs from tuberostemonol4 by the relative configuration of
H-11 and H-12 (C/D ring junction) which are b-oriented in the
latter and a-oriented in neotuberostemonol (9), and by the
isomeric disposition of the allylic alcohol residue present in both
alkaloids.14 Later, this alkaloid was also isolated from roots of
S. sessilifolia.8
epi-Bisdehydroneotuberostemonine J (10), also named by the
same authors as epi-bisdehydrotuberostemonine J, was found in
the dried roots of S. tuberosa.1 It displays a ring A pyrrole unit,
and its relative stereochemistry resembles that of tuber-
ostemonine J (5), except for H-18 which is proposed to be a-
oriented in epi-bisdehydroneotuberostemonine J (10) while it is
b-oriented in tuberostemonine J (5) and in most of the other
Stemona alkaloids bearing the a-methyl-g-butyrolactone moiety
attached to C-3. Its absolute chemical structure was claimed to
have been established by X-ray crystallographic analysis.1
9a-Bisdehydrotuberostemonine (11) also displays a pyrrole
ring and it was isolated from the roots of S. tuberosa.15 Its
structure was assigned as the 9a epimer of bisdehydrotuber-




























































View Article Onlinecombination of HRMS, IR, 1D- and 2D-NMR experiments.15
9a-Bisdehydrotuberostemonine A (12) was also isolated from the
same source and had its structure proposed by analogy to 9a-
bisdehydrotuberostemonine (11), except for the substitution of
the a-methyl-g-butyrolactone moiety attached to C-3 for
a hydroxybutanoyl side chain. Tridehydrotuberostemonine (13)
was also isolated from S. tuberosa and its structure was assigned
as for the two preceding alkaloids. It can be regarded as the
dehydrogenation product at C-8/C-9 of 9a-bisdehydrotuber-
ostemonine (11).15
Sessilifoline A (14) as well as the aforementioned sessilifoline B
(4), was obtained from the stems of S. sessilifolia.11 Its structure
was assigned based on HRMS and spectroscopic methods,
particularly 1D- and 2D-NMR experiments. It is proposed to beFig. 3 Stemona alkaloids of the
This journal is ª The Royal Society of Chemistry 2010an oxygenated derivative of tuberostemonine N (7) with a b-
oriented oxygen bridge between C-5 and C-9a giving rise to an
unusual ring system.2.2 Stemoamide group
In addition to the nine Stemona alkaloids already belonging to this
group, represented by the structure of stemoamide (15) reported
in our original review article,4 25 new representatives displaying
the tricyclic 2H-furo[3,2-c]pyrrolo[1,2-a]azepine nucleus have
been reported in the review period (Fig. 3): protostemonamide
(16), saxorumamide (17), isosaxorumamide (18), neo-
stemocochinine (19), isoneostemocochinine (20), stemocochinin
(21), 13-demethoxy-(11S*,12R*)-dihydroprotostemonine (22),stemoamide group (15–40).




























































View Article Onlinebisdehydrostemocochinine (23), isobisdehydrostemocochinine
(24), dehydroprotostemonine (25), oxyprotostemonine (26),
neostemofoline (27), sessilifoliamide A (28), bisdehy-
droneostemoninine (29), bisdehydrostemoninine A (30), bisde-
hydrostemoninine B (31), bisdehydrostemoninine (32),
isobisdehydrostemoninine (33), stemoninine A (34), stemoninine
B (35), dihydrostemoninine (36), oxystemoninine (37), stemoe-
nonine (38), 9a-O-methylstemoenonine (39), oxystemoenonine
(40).
Protostemonamide (16) was isolated from the roots of S. ses-
silifolia together with 12 previously known compounds. It was
described as being an oxidation product of protostemonine based
on spectrometric and spectroscopic data, including 1D- and 2D-
NMR. Its NMR data are characteristic of protostemonine-type
alkaloids lacking the saturated a-methyl-g-butyrolactone at C-3,
and its relative configuration was assigned to be the same as that of
protostemonine by a ROESY experiment.16
Saxorumamide (17) and isosaxorumamide (18) were obtained
from the roots of S. saxorum collected in Vietnam, and their
structures were assigned based on spectrometric and spectro-
scopic methods. The presence of an a,b-unsaturated-g-butyrol-
actone was revealed by characteristic UV and IR absorptions,
and comparison of its NMR data with those from stemocochinin
(21) revealed that saxorumamide (17) can be regarded as the
oxidation product of stemocochinin (21), featuring a carbonyl
group and lacking the a-methyl-g-butyrolactone at C-3 present
in 21. The NMR data for saxorumamide (17) and iso-
saxorumamide (18) revealed that both shared the same structure
except for the relative configuration at the C-11–C-12 bond:
(11S*,12S*) for 17 and (11S*,12R*) for 18. This assignment is
corroborated by the comparative analysis of their 1H- and 13C-
NMR spectral data which revealed major differences in chemical
shifts for H-10, H-11, H-12 and H-13 as well as for C-10, C-11,
C-12 and C-13.17
Neostemocochinine (19) and isoneostemocochinine (20) were
isolated as a 1 : 1 mixture from the roots of S. cochinchinensis
and were shown to be interconvertible in basic solvents at room
temperature.18 Their structures were assigned by comparison of
their spectral data with those available for stemocochinin (21;
alternative spelling stemocochinine), which displays an a-methyl-
g-butyrolactone at C-3,19 and also correlate reasonably well with
those for saxorumamide (17) and isosaxorumamide (18), which
bear a carbonyl group at C-3.
Stemocochinin (21) was isolated from the roots of S. kerri,19 S.
curtisii19 and S. cochinchinensis,19 and its structure was assigned
based on the data available for protostemonine4 which bears
a methoxy group at C-13 and a Z-configured double bond at
C11–C12. This alkaloid was also isolated from roots of Viet-
namese S. saxorum.17 13-Demethoxy-(11S*,12R*)-dihy-
droprotostemonine (22) was obtained from the stems and leaves
of S. japonica along with stemocochinin (21). The two
compounds appeared to differ in the configuration at C-11 and
C-12, the relative configuration of 22 being established by
ROESY experiments. In the same report20 the relative configu-
rations at C-11 and C-12 in stemocochinin (21), which had not
been addressed in the original publication,19 were proposed to be
11S* and 12S*. However, this proposal is not in accordance with
the structures put forward for bisdehydrostemocochinine (23)
and isobisdehydrostemocochinine (24), isolated from the roots of1912 | Nat. Prod. Rep., 2010, 27, 1908–1937S. cochinchinensis, which had their relative configurations
assigned by ROESY experiments as 12R and 12S, respectively.18
Dehydroprotostemonine (25) was obtained from the roots of
S. kerrii and S. curtisii and its structure was established after
extensive 2D-NMR experiments as the 7,8-dehydro derivative of
protostemonine, which was also isolated from S. kerrii and
S. cochinchinensis.19 In the same study, oxyprotostemonine (26)
was also described from the roots of S. kerrii and S. curtisii, and
it was proposed to bear an oxygen bridge between C-1 and C-8
by 2D-NMR and NOESY experiments. Alkaloids 25 and 26
were also isolated from roots of S. saxorum17 and S. cochinchi-
nensis.18
Neostemofoline (27) was isolated from stems and leaves of
S. japonica20 and its structure, bearing the characteristic n-butyl
side chain at C-3 and an oxygen bridge between C-2 and C-6, was
established by comparison of its NMR data with those from
stemofoline.4
Sessilifoliamide A (28), one of the four sessilifoliamides iso-
lated from the roots of S. sessilifolia, is the only sessilifoliamide
that displays the tricyclic 2H-furo[3,2-c]pyrrolo[1,2-a]azepine
ring system.8 Its structure was established by NMR studies and
single-crystal X-ray diffraction analysis. Its absolute stereo-
chemistry was determined after correlation studies involving
sessilifoliamide A (28) and stemoninoamide (also known as
tuberostemoamide) – the corresponding derivatives lacking the
spiro furofuran ring system – and derivatization as the Mosher’s
ester. Bisdehydroneostemoninine (29) was isolated from the
roots of S. tuberosa and its structure was established by NMR
studies and X-ray diffraction analysis.21
Bisdehydrostemoninine A (30) and bisdehydrostemoninine B
(31) were isolated from the roots of S. tuberosa.21 The 1H- and
13C-NMR spectra of these alkaloids revealed that they con-
tained the basic skeleton of stemoninine alkaloids with a side
chain attached to C-3, which is reminiscent of the ubiquitous
a-methyl-g-butyrolactone moiety, as represented by bisdehy-
drostemoninine (32). The latter alkaloid was also isolated
from the same source as bisdehydrostemoninine A (30) and
bisdehydrostemoninine B (31), and its structure was established
by spectroscopic studies and X-ray diffraction analysis. Iso-
bisdehydrostemoninine (33) was also isolated from S. tuberosa,
and it was revealed to be a stereoisomer of bisdehy-
drostemoninine (32) with the configuration at C-11 assigned
based on NOE experiments.21 Alkaloids 32 and 33 were also
isolated from roots of S. sessilifolia.22
The relative configuration of bisdehydrostemoninine A (30)
was confirmed by X-ray diffraction analysis, which also allowed
the authors to establish the presence of an unsaturated a-methyl
butyrolactone at the spiro position, in contrast to stemoninine
A (34) and stemoninine B (35), which display a saturated
a-methyl butyrolactone at that position. These alkaloids were
isolated from S. sessilifolia and their structures were assigned
based on spectroscopic data which revealed that they con-
tained the basic stemoninine skeleton with an unsaturated ring
A. The relative configuration of stemoninine A (34) was
proposed by NOE experiments, and the b-orientation of H-18
was assumed to be the same as that in most Stemona alkaloids.
The NMR data for stemoninine B (35) displayed significant
differences in relation to those of stemoninine A (34), particu-




























































View Article OnlineNOE correlations allowed their assignment as epimers at the
spiro position.23
Dihydrostemoninine (36) was isolated in trace amounts from
the roots of S. sessilifolia, and its structure and relative config-
uration was unambiguously established by X-ray crystallog-
raphy, revealing it to be the 12,13-dihydro derivative of
stemoninine. Due to the limited amount of dihydrostemoninine
(36) available, no spectroscopic or spectrometric data were
recorded.24
Oxystemoninine (37) was isolated from the roots of S. tuberosa
and its 1H- and 13C-NMR spectra were similar to those of ste-
moninine, except for the signals of ring D which resembled those
of oxystemoenonine (40).25 Stemoenonine (38) and 9a-O-methyl-
stemoenonine (39) were also isolated from the same source, and
comparison of the 1D- and 2D-NMR data for 38 and bisdehy-
drostemoninine (32) revealed that rings B, C, D and E were
similar and that an hydroxyl group was attached at C-9a while an
enone moiety was present in ring A. The NMR data for 9a-O-
methylstemoenonine (39) displayed an additional O-methyl
signal which was assigned to the 9a position. Oxystemoenonine
(40) was also isolated from S. tuberosa and the proposed struc-
ture corresponds to the hydrated form of stemoenonine (38),
with the b-orientation of the hydroxyl group at C-12 assigned by
ROESY experiments. It is to be noted that the methyl groups at
C-13 in oxystemoninine (37) and in oxystemoenonine (40) do not
have the same relative configuration as in sessilifoliamide A (28),
stemoninine A (34), stemoninine B (35) and dihydrostemoninine
(36).2.3 Tuberostemospironine group
The tuberostemospironine group is characterized by the presence
of a spiro-g-butyrolactone attached to C-9 of its pyrrolo[1,2-Fig. 4 Stemona alkaloids of the tuberostemospironine group (41–46).
This journal is ª The Royal Society of Chemistry 2010a]azepine nucleus, and is represented by the parent alkaloid
tuberostemospironine (41). Since our first review, five new
representatives have been described: 10-hydroxycroomine (42),
6-hydroxycroomine (43), dehydrocroomine (44), tuber-
ospironine (45) and sessilifoliamine A (46) (Fig. 4).
10-Hydroxycroomine (42) was isolated from the roots of S.
tuberosa collected in Yunnan province, China, and its structure
was elucidated by spectral analyses: 2D-NMR studies established
the hydroxyl group at C-10 and NOE experiments indicated its
cis relationship with the methyl group at C-11.15
6-Hydroxycroomine (43) was first reported to be isolated from
S. tuberosa.26 Additionally, it was isolated from the same species
and named as 6a-hydroxycroomine27 while on another occasion
it was misrepresented as the corresponding 6b epimer.15 The
NMR data of 43 resembled those from croomine4 but containing
an hydroxyl group. COSY spectroscopy allowed to establish it at
C-6 of the azepine ring, while NOESY experiments determined it
to be a-oriented.
Dehydrocroomine (44) was also isolated from S. tuberosa by
Lin and co-workers,15 and a detailed analysis of its NMR spectra
revealed that it had the same basic skeleton as croomine. It
should be noted that the relative configuration at C-9 proposed
for dehydrocroomine (44), based on NOE difference experi-
ments, is not the one observed in croomine, 10-hydroxycroomine
(42) and 6-hydroxycroomine (43).
Tuberospironine (45) was first isolated as a minor component
from the root tubers of S. tuberosa collected in Guangxi prov-
ince, China.13 Later this alkaloid was isolated from the same
species collected in Yunnan province.15 Its proposed structure
can be considered as an hydration product of dehydrocroomine
(44) in which the hydroxyl group at C-10 is trans-oriented relative
to the methyl group at C-11. Additionally, the configuration at
C-9 assigned by ROESY experiments was distinct from that of
croomine and 10-hydroxycroomine (42). Based on the absolute
configuration previously reported for tuberostemonine metho-
bromide and considering the biogenetic relationships in the
Stemona alkaloids, the authors13 tentatively inferred the absolute
configuration of tuberospironine (45) as depicted in Fig. 4.
Sessilifoliamine A (46) was isolated from the roots of S. ses-
silifolia, and the presence of a 2-methyl-2-butenolide ring was
established by its strong UV absorption and HMBC correla-
tions, which indicated that the butenolide ring was fused to the
C-5–C-6 bond of the perhydroazepine nucleus. Its relative
stereochemistry was then established by NOESY experiments,
which was in agreement with the results of the molecular
modeling studies.28 It should be mentioned that this is the first
Stemona alkaloid to display a 2-methyl-2-butenolide ring fused
to C-5 and C-6 in the azepine ring.2.4 Stemonamine group
The stemonamine group is represented by the parent alkaloid
stemonamine (47)4 and is characterized by the presence of the
cyclopenta[1,2-b]pyrrolo[1,2-a]azepine nucleus. Five new repre-
sentatives have been reported since our first review,4 and all these
have an additional a-methyl-b-methoxy unsaturated spiro-g-
butyrolactone (Fig. 5).
Sessilistemonamines A–C (48–50, respectively) were isolated
from the root extract of S. sessilifolia and had their structuresNat. Prod. Rep., 2010, 27, 1908–1937 | 1913




























































View Article Onlineproposed based on extensive 1D- and 2D-NMR spectroscopy.24
These are the first stemonamine-type alkaloids to display
a butyrolactone ring fused to C-11 and C-12 of the basic nucleus
of this group.
The relative configuration of sessilistemonamine A (48) was
assigned based on NOE difference spectra, and this series of
compounds was proposed to be isomeric at C-9a, C-10, C-11 and
C-12 carbons. In that respect, sessilistemonamine A (48) and
sessilifoliamine B (49) were proposed to have opposite configu-
rations at all the stereogenic centers mentioned before, while
sessilifoliamine B (49) and sessilifoliamine C (50) had only the
stereocenter at C-10 conserved. Sessilistemonamine A (48) and
sessilifoliamine C (50) were epimeric at the C-10 stereocenter.24
Isooxymaistemonine (51) and isomaistemonine (52) were also
isolated from the roots of S. sessilifolia collected in Jiangxi
Province, China.22 The 1H- and 13C-NMR data for iso-
oxymaistemonine (51) were closely related to that of oxy-
maistemonine,4 and NOESY experiments indicated that 51 and
52 differed by their oxidation state at C-8. The NMR data for 52
were similar to those of 51, with the exception of the replacementFig. 6 Stemona alkaloids of the p
1914 | Nat. Prod. Rep., 2010, 27, 1908–1937of the carbinolic group at C-8 by a methylene group in iso-
maistemonine (52). Alkaloid isomaistemonine (52) was also
isolated from S. sessilifolia (collected in Anhui Province,
China),16 S. saxorum,17 S. japonica20 and S. cochinchinensis.182.5 Parvistemoline group
The parvistemoline alkaloids are characterized by the presence of
a substituent attached to C-9 of the pyrrolo[1,2-a]azepine nucleus
and by the lack of the B–C ring fusion commonly found in the
other groups of Stemona alkaloids. This definition comprises the
previously reported representatives and eight new ones (Fig. 6):
sessilifoliamide B (54), sessilifoliamide C (55), sessilifoliamide D
(56), stemaphylline (57), stemaphylline N-oxide (58), sticho-
neurine A (59), stichoneurine B (60) and protosetemodiol (61).4
Sessilifoliamides B–D (54–56) were isolated from the roots of
S. sessilifolia and their structures were assigned based on spec-
troscopic studies and chemical correlations. Sessilifoliamides B
and C (54 and 55) were chemically correlated with sessilifolia-
mide A (28, stemoamide group) which had its structure unam-
biguously established by X-ray diffraction analysis.
Sessilifoliamide D (56) was reduced with LiBH4 to afford
a mixture of two C-11 epimers, one of them also being prepared
via LiBH4 reduction of sessilifoliamide B (54).
8
Stemaphylline (57) and stemaphylline N-oxide (58) were iso-
lated from the root extract of S. aphylla in the first phytochemical
report on this species. Their structures were based on HRMS,
1D- and 2D-NMR spectroscopy and 58 was obtained from the
H2O2/Na2WO4 oxidation of stemaphylline (57).
29
Stichoneurines A and B (59 and 60) were obtained from the
root extracts of Stichoneuron caudatum as an inseparable mixture
and had their structures assigned based on HRMS and NMR
studies.26 The presence of an a-methyl-g-butyrolactone attached
to C-3 was shown by mass spectrometry. The C-10–C-11
stereochemistry proposed in 59 and 60 is different from that
observed in sessilifoliamides B and C (54 and 55), as well as the
configuration at C-13 when compared with sessilifoliamide B
(54).8
Protostemodiol (61) was obtained from the stems and leaves of
S. japonica, and its NMR data revealed it to be related to pro-
tostemonine, while its molecular weight was in accordance with
the incorporation of an additional water molecule to thearvistemoline group (53–61).




























































View Article Onlinemolecular formula of protostemonine. Its structure was assumed
to be the result of an oxidative cleavage of the C-8–O bond, with
inversion of configuration at C-8.202.6 Stemofoline group
Due to the emergence of fourteen new representatives of
Stemona alkaloids displaying the ring system characteristic of
stemofoline (62),4 it seems appropriate to create the stemofoline
family to encompass those alkaloids displaying a tetracyclic
moiety with an oxygen bridge between C-2 and C-8 and
a carbon–carbon bond involving C-3 and C-7 of the pyr-
rolo[1,2-a]azepine ring system. Besides the previously reported
stemofoline, oxystemofoline, methoxystemofoline, parvistemoni-
nine and parvistemoninol,4 this group now encompasses
(11S,12R)-dihydrostemofoline (63), methylstemofoline (64), (20R)-
hydroxystemofoline (65), (20S)-hydroxystemofoline (66), (30R)-
stemofolenol (67), (30S)-stemofolenol (68), stemofolinoside (69),
16,17-didehydro-16(E)-stemofoline (70), 10,20-didehydrostemofoline-
N-oxide (71), 16,17-didehydro-(4E)-(16E)-stemofoline (72),
stemoburkilline (73), 6b-hydroxystemofoline (74), 16-hydroxy-
stemofoline (75) and isostemofoline (76) – see Fig. 7.
(11S,12R)-Dihydrostemofoline (63) was isolated from the root
extract of S. burkillii.30 Its structure and relative configuration
were determined via spectroscopic data and from comparison
with synthetic (11S,12S)-dihydrostemofoline by syn hydrogena-
tion of stemofoline.
Methylstemofoline (64) was reported to be isolated from the
root extract of an unidentified Stemona species.31 It was the first
C19 stemofoline derivative to be reported, and its planar struc-
ture and relative configuration were proposed based on HRMS
and 1D- and 2D-NMR spectroscopies.
The isolation of 20-hydroxystemofoline was reported for the
first time from the roots and rhizomes of S. collinsae.32 ItsFig. 7 Stemona alkaloids of the
This journal is ª The Royal Society of Chemistry 2010structure was proposed based on its physical and spectral data
but the configuration at C-20 was not addressed at that point.32
Later, X-ray diffraction analysis of the CH2Cl2 solvate of 2
0-
hydroxystemofoline isolated from S. collinsae established its 20S
configuration (66).33
The two C-20 epimers of 20-hydroxystemofoline were isolated
from the root extract of an unidentified Stemona species.31 They
displayed different mobility on silica gel and similar but different
1H- and 13C-NMR spectra. Their epimeric nature was confirmed
after oxidation of (20S)-hydroxystemofoline (66) to the corre-
sponding ketone, followed by sodium borohydride reduction,
which afforded a 62 : 38 mixture of (20S)-hydroxystemofoline
(66) and (20R)-hydroxystemofoline (65).31 20-Hydroxystemofo-
line was also isolated from roots of S. curtisii,19 S. cochinchi-
nensis19 and S. burkillii,30 while the 20S alkaloid (66) was also
isolated from S. aphylla.29
Additionally, (30R)-stemofolenol (67) and (30S)-stemofolenol
(68) were also found in the above-mentioned unidentified Ste-
mona species as a 1 : 1 mixture by thin-layer chromatography.31
The 13C-NMR spectrum revealed two methyl resonances which
were assigned to the methyl groups at the C-40 position. The 1 : 1
mixture of 67 and 68 was oxidized to provide a single ketone
which upon reduction with sodium borohydride regenerated the
mixture above. The same authors described the isolation of the
first glycosylated Stemona alkaloid, stemofolinoside (69). The
position of the glycoside at C-5 was evident from 2D-NMR
experiments, and the 13C-NMR spectrum indicated it to be
a glucopyranoside, presumably with a D-configuration.31
16,17-Didehydro-16(E)-stemofoline (70), also known as dide-
hydrostemofoline,32 (11Z)-10,20-didehydrostemofoline,29,31 10,20-
didehydrostemofoline33 and asparagamine A,2,32,33 was isolated
from the dried roots of S. collinsae together with its isomer 16,17-
didehydro-4(E),16(E)-stemofoline (72).34 Their structures were
proposed based on physical and spectroscopic data, particularlystemofoline group (62–76).




























































View Article Onlinethe similarity of the 1H-NMR data with those from stemofoline4
and the presence of two olefinic hydrogens on the side chain. The
structure of 16,17-didehydro-4(E),16(E)-stemofoline (72) was
assigned based on its similarity to 16,17-didehydro-16(E)-ste-
mofoline (70) and on the observation that 72 was converted to 70
upon irradiation by light, which raises the possibility of the latter
being an artifact. 10,20-Didehydrostemofoline-N-oxide (71) was
reported to be isolated from the roots of an unidentified Stemona
species, in addition to alkaloids 70 and 72.31 The structure of 71
was assigned based on spectral data and chemical correlation
with 70.31 Additionally, alkaloid 70 was also isolated from roots
of S. aphylla.29
Stemoburkilline (73) was first described from the root extract
of S. burkillii.30 Its structure was proposed based on physical and
spectroscopic data, which revealed the presence of a hemiacetal
and a double bond at C-11–C-12. Additionally, its 11E config-
uration was assigned by NOESY experiments. Despite the
isolation of (11S,12R)-dihydrostemofoline (63) from the same
sample, it was shown that stemoburkilline (73) is not an artifact
produced under either acidic or basic conditions. Further studies
involving semisynthesis from (11Z)-10,20-didehydrostemofoline
revealed that stemoburkilline (73) is the Z-isomer and not the E-
isomer as initially reported.35
6b-Hydroxystemofoline (74) and 16-hydroxystemofoline (75)
were isolated from S. japonica, and their structures were assigned
after 1D- and 2D-NMR studies.20
The total synthesis of isostemofoline (76) was the subject of an
article by Kende et al. in 1999,36 in which they note that isolationFig. 8 Stemona alkaloids of the s
1916 | Nat. Prod. Rep., 2010, 27, 1908–1937of this compound was achieved in the laboratory of Yang Ye at
the Shanghai Institute of Materia Medica. Although Kende et al.
provide characterization data, a full description of its isolation
and structural elucidation do not seem to have been published.2.7 Stemocurtisine group
The pyrrolo[1,2-a]azepine ring, which is the hallmark of all the
previously described Stemona alkaloids, is replaced in this group
by the pyrido[1,2-a]azepine nucleus (Fig. 8). The first pyrido[1,2-
a]azepine Stemona alkaloid to be described was stemocurtisine
(77), which was found in the root extract of S. curtisii.37 The
structure was established by extensive NMR experiments and
eventually confirmed by X-ray diffraction analysis. Its absolute
configuration is not known, but it was assumed based on previ-
ously isolated Stemona alkaloids with similar C/D ring archi-
tecture. The same structure as that of stemocurtisine (77) (Fig. 8)
was proposed for an alkaloid named pyridostemin, which was
isolated from the roots of Stemona sp. HG 915.19
Stemocochinamine (78) was isolated from the roots of S.
cochinchinensis. Its structure was proposed based on 1D- and 2D-
NMR spectroscopy, and the relative configuration determined
by ROESY experiment. The configuration at C-14 was assumed
based on biosynthetic considerations. The possibility of sem-
ocochinamine (78) being an artifact due to the utilization of
a small amount of aqueous ammonia can not be excluded.18
Oxystemokerrilactone (79) was isolated from the roots of
S. saxorum and its structure assigned based on HRMS andtemocurtisine group (77–88).




























































View Article Online1D- and 2D-NMR data, including ROESY experiment correla-
tions which allowed the authors to propose the same relative
configuration as in oxystemokerrin (87).17 The roots of
S. cochinchinensis also yielded cochinchistemonine (80), which had
its structure established by spectral analyses and by single-crystal
X-ray diffraction. It displays a hydroxypropyl side chain attached
to C-4 and a cyclopentane ring fused to C-9–C-10, with a a-
methyl-b-methoxy unsaturated spiro-g-butyrolactone at C-13.38
Cochinchistemoninone (81) was obtained from the roots of
S. saxorum and had its structure proposed based on spectro-
scopic methods.17 Comparison of its 13C-NMR data with those of
cochinchistemonine (80) revealed that a carbonyl instead of
a hydroxyl group was located at C-12 in 81. From ROESY
experiment data, it was proposed that cochinchistemoninone
(81) has the opposite configuration at the spirocenter (C-13) to
that in cochinchistemonine (80).
Stemokerrin (82) was first isolated from roots of S. kerrii19 and
later from S. saxorum.17 Its structure was elucidated by analogy
to protostemonine chloroform solvate,4 but the configuration at
C-4 in 82 is opposite to that at C-3 in protostemonine.19
Stemokerrin-N-oxide (83) which was isolated from the roots of
S. saxorum,17 had its structure established by spectroscopic
methods and its NMR data has similarity to that described for
methoxystemokerrin-N-oxide (84), isolated from S. kerrii.19 This
later alkaloid displayed almost identical NMR data toFig. 9 Stemona alkaloids of the m
This journal is ª The Royal Society of Chemistry 2010stemokerrin (82), except for the methoxy group in the propyl side
chain replacing the secondary hydroxyl group.19
Stemosessifoine (85), with an unprecedented skeleton, was iso-
lated from the roots of S. sessilifolia and its structure was assigned
by combination of spectrometric and spectroscopic data.22
Stemocurtisinol (86) was isolated from the roots of S. curtisii
and had its structure established by spectral data interpretation
and X-ray diffraction analysis.39 Oxystemokerrin (87) and oxy-
stemokerrin-N-oxide (88) were isolated from the roots of
S. kerrii,19 whereas 87 was also isolated from the roots of
S. curtisii,19 Stemona sp.19 and S. saxorum.17 Additionally, the
phytochemical investigation of this later species also yielded
alkaloid 88. Oxystemokerrin (87) and oxystemokerrin-N-oxide
(88) also have an oxygen bridge between C-1 and C-9, and an
identical pattern was observed in their 2D-NMR connectivities.
The N-oxide in 88 was suggested based on the characteristic loss
of the side chain and an oxygen atom in its mass spectrum.192.8 Miscellaneous
The miscellaneous group comprises those Stemona alkaloids that
do not display the pyrrolo[1,2-a]azepine or pyrido[1,2-a]azepine
nucleus, together with those that have either of these structural
features but are so far the only representatives of their groups.
Since our first review on this topic, sixteen new alkaloidsiscellaneous group (89–104).




























































View Article Onlinebelonging to this class have being reported (Fig. 9): neo-
tuberostemoninol (89), maireistemoninol (90), sessilifoliamide I
(91), sessilifoliamide E (92), sessilifoliamide F (93), tubero-
stemoline (94), sessilifoliamide G (95), sessilifoliamide H (96),
neotuberostemonone (97), epoxytuberostemonone (98), sessili-
foliamide J (99), tuberocrooline (100), parvineostemonine (101),
sessilistemonamine D (102), 1,9a-seco-stemoenonine (103) and
tuberostemoenone (104).
Neotuberostemoninol (89) was isolated from a herbal sample
of S. tuberosa as colorless prismatic crystals. It incorporates a 1-
azabicyciclo[4.3.1]decanone ring system and its NMR spectra
were comparable to those previously described for tuber-
ostemoninol.4 Its relative configuration was unambiguously
established by X-ray diffraction analysis.14 Later on, this alka-
loid, as well as alkaloids 90, 97 and 98, were isolated from the
roots of S. mairei.9
Maireistemoninol (90) had its structure established by spec-
troscopic analyses and high-resolution ESI-MS. Its 13C-NMR
spectrum was similar to that for tuberostemoninol,4 except for
the change in the position of the hydroxyl group, which was
assigned to C-8 based on the HMBC spectrum. The ROESY
spectrum suggested H-1 and H-8 to be a- and b-oriented,
respectively. The configuration of C-9, however, was not
unambiguously depicted.9
Sessilifoliamide I (91) was obtained from the roots of S. ses-
silifolia. Its molecular formula and NMR data suggested it to
have the same planar structure as tuberostemoninol4 and neo-
tuberostemoninol (89), and its relative stereochemistry was
established after X-ray crystallographic analysis.40
The roots of S. sessilifolia afforded sessilifoliamides E (92), F
(93), G (95) and H (96) which had their structures unequivocally
elucidated by NMR spectroscopy, HRMS and X-ray diffraction
analyses.41 Sessilifoliamide F (93) was also isolated from the
roots of S. tuberosa15 collected in Yunnan province, in addition
to the alkaloids 94,15,42 10015 and 104.15 Tuberostemoline (94) is
structurally closely related to the above sessilifoliamides and had
its structure assigned as the C-1 epimer of sessilifoliamide F (93)
on the basis of 1D and 2D NMR spectroscopy. Upon inspection
of the structures of tuberostemoline (94) and sessilifoliamide G
(95), the latter can be considered to be derived by formation of
a transannular hemiacetal between the hydroxyl group at C-1
and the C-9 carbonyl present in tuberostemoline (94).
Sessilifoliamide H (96) had its structure established by spec-
troscopic studies and X-ray diffraction analysis, and it is struc-
turally related to the previously isolated tuberostemonone,4
displaying the characteristic 9-membered lactam ring.41 The same
structural feature can be found in neotuberostemonone (97) and
epoxytuberostemonone (98) which were isolated from the roots
of S. mairei and had their structures proposed based on
a combination of 1D- and 2D-NMR and HRMS.9 Their ster-
eoconfiguration was assigned by ROESY experiments, which
indicated that neotuberostemonone (97) differs from tuber-
ostemonone by the relative configurations at C-12 and C-13.
Although the configuration of H-9 was not unambiguously
depicted, ROESY correlations have indicated that it is b-
oriented.9 The structure of the latter alkaloid may be related to
neotuberostemoninol (89) via a putative retroaldol trans-
formation, although they differ in the stereochemistry at C-11, C-
12 and C-13. The 1H- and 13C-NMR spectra of1918 | Nat. Prod. Rep., 2010, 27, 1908–1937epoxytuberostemonone (98) were similar to those of neo-
tuberostemonone (97) except for two methine carbons in 97
changing to a 9,10-epoxy group in 98. The correlation observed
in the ROESY experiment between the methyl group at C-13 and
H-12, the methyl group at C-13 and the ethyl group at C-10, and
between H-11 and H-13, together with the absence of correlation
between H-11 and H-12, led to the assignment of a trans-fused g-
butyrolactone at C-11–C-12.9
Sessilifoliamide J (99) was isolated from the roots of S. sessi-
lifolia and its structure was established after NMR studies and
X-ray diffraction analysis. It may be regarded as the lower
homologue of croomine, with a piperidine ring replacing the
characteristic azepine nucleus of most of the Stemona alkaloids.28
Tuberocrooline (100) was isolated from the roots of S. tuber-
osa and its structure was proposed based on 1D and 2D NMR
analyses which revealed that its structure was equivalent to that
of croomine4 with cleavage of the C-3–N bond. The relative
configuration of most of the stereocenters was proposed based on
a ROESY experiment, except that of C-3 which remained
unassigned.15
Parvineostemonine (101) was isolated from the stems and
leaves of S. parviflora and had its structure established by spec-
troscopic methods. This alkaloid features a spirotetracyclic
structure with a two-carbon bridge between C-3 and C-9 of the
pyrroloazepine moiety. One of these carbons (C-11) is part of
a spirobutenolide ring (ring D) while the other one (C-10) bears
an ethyl substituent.43
Sessilistemonamine D (102), obtained from the roots of S.
sessilifolia, had its structure elucidation proposed based on
NMR spectroscopy and HRMS, which revealed a tricyclic core
formed by a pyrrolo[1,2-a]azepine nucleus fused to a cyclohexane
ring, in addition to the presence of two g-butyrolactones: one
attached at C-3 and another one connecting C-11 to C-13. The
relative configuration was proposed based on an NOE difference
spectrum.44
1,9a-seco-Stemoenonine (103) was isolated from the roots of
S. tuberosa and its structure was assigned by combination of
spectrometric and spectroscopic analyses as the oxidative
cleavage product of stemoenonine (38).25
Tuberostemoenone (104) was isolated from the roots of
S. tuberosa and it was shown to display a novel skeleton.153 Natural sources
3.1 Stemonaceae family
The Stemonaceae family is still the only source of the Stemona
alkaloids, although this family has also produced non-alkaloid
constituents45 and, more recently, Pandanus alkaloids.46 An
update of the Angiosperm Phylogeny Group classification for
the orders and families of flowering plants (APGII) describes
Stemonaceae as a member of the order Pandanales (including
Cyclanthaceae, Pandanaceae, Stemonaceae, Triuridaceae and
Velloziaceae),47 and not Discoreales as formerly reported.4 The
reclassification of Stemonaceae in this order was supported by
molecular phylogenetic analyses of monocots.48 Moreover, the
isolation of pandamines (typical compounds of Pandanus
amaryllifolius from Pandanaceae) from Strichoneuron calcicola isThis journal is ª The Royal Society of Chemistry 2010
Table 1 Stemona alkaloids isolated from Stemonaceae speciesa
Species Alkaloid Ref.











































































View Article Onlineof great chemosystematic importance, and corroborates the
inclusion of this family in the order Pandanales.46
Recently, the genus Stichoneuron was reviewed,48 and three
new species from Thailand and Malaysia were described (S.
bognerianum Duyfjes, S. calcicola Inthachub and S. halabalensis
Inthachub) in addition to the already known S. membranaceum
Hook. f. and S. caudatum Ridley. A new Stemona species (S.
hutanguriana W. Chaukul) from Thailand was also described.49
The classification of Pentastemona as a genus from Penta-
stemonaceae and not from Stemonaceae is still discussed in the
literature.48 In the list of the flowering families from APGII,47
Pentastemonaceae is considered a synonym of Stemonaceae
(accepted family name), suggesting that Pentastemona is
a member of the latter family.
Oxystemokerrin 87 19
Parvistemonine 19
Stemona aphylla Stemaphylline 57 29









































20-Hydroxystemofoline 65 or 66 19
Stemocurtisine (aka pyridostemin) 77 37
Stemocurtisinol 86 39
Oxystemokerrin 87 19








Stemofoline 62 203.2 Phytochemical studies
Up to 1998, the phytochemical investigation of the Stemonaceae
had been reported for eight species, six of them from Stemona
and two from Croomia.4 Following this, a considerable increase
in the number of investigated species was observed. Fifteen
Stemonaceae species (fourteen Stemona and one Stichoneuron
species) were chemically studied, most of them belonging to
Stemona (Table 1). Among the reported Stemona species, six of
them have been previously investigated,4 and some studies were
also done with unidentified Stemona species. No additional
phytochemical study of Croomia species was found in the
literature.
The phytochemical studies of the Stemonaceae species resulted
in the isolation of 97 new Stemona alkaloids, most of them from
S. sessilifolia and S. tuberosa. On the other hand, only one
alkaloid was isolated from S. parviflora [parvineostemonine
(101)] and no new alkaloid was identified from the investigation
of S. cf. pierrei. The phytochemical investigation of the Sticho-
neuron genus was reported for the first time and only two alka-
loids [stichoneurine A (59) and stichoneurine B (60)] were
isolated from S. caudatum. Among the new isolated alkaloids,
stemocochinin (21), dehydroprotostemonine (25), oxy-
protostemonine (26), isomaistemonine (52), (20S)-hydroxy-
stemofoline (66), (11Z)-10,20-didehydrostemofoline (70) (also
known as 16,17-didehydro-16(E)-stemofoline) and oxy-
stemokerrin (87) were the most frequently isolated.
Alkaloids from the stemoamide (II), stemofoline (VI) and
stemocurtisine (VII) groups (Fig. 1) were the most frequently
found in the investigated species. Moreover, S. sessilifolia was the
species characterized by the presence of alkaloids from different
groups, mostly from stemoamide (II) and miscellaneous groups.
S. sessilifolia, S. tuberosa, S. japonica, S. mairei and S. parvi-
flora are the only previously studied species,4 and the contribu-
tion of their phytochemical re-investigation to the identification
of unprecedented alkaloids in each species can be seen by
examination of Fig. 10. Re-investigation of S. parviflora showed
a reduction in the number of isolated alkaloids, while a consid-
erable increase was observed for S. sessilifolia, S. tuberosa and S.
mairei, and no variation was observed for S. japonica. In addi-
tion, most alkaloids isolated in the period of 1999–2009 were
reported for the first time in the investigated species.
In summary, the phytochemical investigation of the Stemo-
naceae species has involved their roots, rhizomes, leaves andThis journal is ª The Royal Society of Chemistry 2010 Nat. Prod. Rep., 2010, 27, 1908–1937 | 1919

























Stemona parviflora Parvineostemonine 101 43
Stemona cf. pierrei Protostemonine 56
Stemonine 56















Maistemonine (aka protostemotinine) 17
Protostemonine 17
Stemona sessilifolia Stenine 1 8
2-Oxostenine 2 8
Sessilifoline B 4 11
Neotuberostemonol 9 8
Sessilifoline A 14 11
Stemoamide 15 16
Protostemonamide 16 16
Sessilifoliamide A 28 8,11
Bisdehydrostemoninine 32 22
Isobisdehydrostemoninine 33 22
Stemoninine A 34 23
Stemoninine B 35 23
Dihydrostemoninine 36 24
Sessilifoliamine A 46 28
Stemonamine 47 16
Sessilistemonamine A 48 24
Sessilistemonamine B 49 24
Sessilistemonamine C 50 24
Isooxymaistemonine 51 22
Isomaistemonine 52 16,22
Sessilifoliamide B 54 8
Sessilifoliamide C 55 8
Sessilifoliamide D 56 8
Stemosessifoine 85 22
Table 1 (Contd. )
Species Alkaloid Ref.
Sessilifoliamide I 91 40
Sessilifoliamide E 92 41
Sessilifoliamide F 93 41
Sessilifoliamide G 95 41
Sessilifoliamide H 96 41
Sessilifoliamide J 99 28


















Stemona tuberosa Isostenine (aka neostenine) 3 1
Tuberostemonine J 5 1
Tuberostemonine H 6 1
Tuberostemonine N 7 12







9a-Bisdehydrotuberostemonine A 12 15
Tridehydrotuberostemonine 13 15
Bisdehydroneostemoninine 29 21
Bisdehydrostemoninine A 30 21
































Stichoneuron caudatum Stichoneurine A 59 26
Stichoneurine B 60 26
a aka ¼ also known as.


























































































































View Article Onlinestems, in addition to herbal samples. 1H and 13C-NMR were the
primary means of structure elucidation, while X-ray analysis was
a potent tool for the elucidation of the structures of some
compounds.4 Biological activities
The popular use of herbal extracts from the Stemonaceae family
for the treatment of respiratory diseases and as antihelmintics in
China and in other eastern Asian countries has contributed to the
growing number of pharmacological studies with crude extracts
and isolated alkaloids in the period covered in this review.
The aqueous and total alkaloid extract obtained from S.
tuberosa, and five alkaloids [tuberostemonine J (5), tuber-
ostemonine H (6), epi-bisdehydrotuberostemonine J (10), iso-
stenine (3; also known as neostenine) and neotuberostemonine]
isolated by bioguided fractionation of the total alkaloid extract,
were examined for their antitussive activity in the guinea pig after
cough induction by citric acid aerosol stimulation. Isostenine (3)
and neotuberostemonine displayed the most significant antitus-
sive activity and a further study of the structure–activity rela-
tionship revealed the importance of the saturated tricyclic
pyrrolo[3,2,1-jk][1]benzoazepine nucleus of these alkaloids for
the antitussive activity. In addition, the all-cis configuration at
the tricyclic junction was shown to be the optimal structural
motif for the biological activity.1
Bisdehydrostemoninine (32), isolated from the crude alkaloid
extract of the roots of S. tuberosa, showed significant antitussive
activity in the same assay but displayed markedly lower potency
in cough suppression when compared to neotuberostemonine.21
Another report using citric acid aerosol stimulation of
coughing in (via intraperitoneal and oral administration) in the
guinea pig revealed that croomine may contribute to the anti-
tussive activity of S. tuberosa.15
Stemoenonine (38), 9a-O-methylstemoenonine (39), stemoni-
noamide (also known as tuberostemoamide) and stemoninine,
isolated from roots of S. tuberosa were investigated in the anti-
tussive assay. Stemoninoamide and stemoninine exhibited strongThis journal is ª The Royal Society of Chemistry 2010antitussive activity after oral and intraperitoneal administration
while stemoenonine (38) and 9a-O-methylstemoenonine (39)
were evaluated after intracerebroventricular injection. The major
alkaloids, stemoninine, bisdehydrostemoninine and stemona-
mide, showed strong antitussive effects in the citric acid-induced
guinea pig cough model, respectively, suggesting that S. tuberosa
could be used as an anticough agent.25
The total alkaloid fraction isolated from S. sessilifolia was
demonstrated to inhibit coughing and the main alkaloid
constituents protostemonine, stemospironine and maistemonine
exhibited significant antitussive activity.16
The insecticidal and antifeedant activities of stemofoline4 and
16,17-didehydro-16(E)-stemofoline (70), isolated from roots of
S. collinsae, were examined using the third-instar larvae of the
pyrethroid-resistant diamondback moth. While the activities of
stemofoline were significantly lower than those of alkaloid 70,
the activity of the latter was found to be the strongest among the
stemofoline-based alkaloids at that time.34
The methanolic leaf and root extracts from S. collinsae were
evaluated against neonate larvae of S. littoralis and displayed
very high insect toxicity when compared to those of Aglaia
species, a commercial pyrethrum extract, and azadirachtin. The
activity of S. collinsae was attributed to the predominance of
16,17-didehydro-16(E)-stemofoline (70), also known as didehy-
drostemofoline. In the leaf disk choice assay against fifth-instar
larvae, S. collinsae displayed strong antifeedant activity, whereas
S. tuberosa was characterized by remarkable repellency. The
bioactivity of the latter species was associated with tuber-
ostemonin,e4 which was found to be the dominant alkaloid in the
roots of S. tuberosa, showing outstanding repellency but no toxic
effects.32 In another report on the insecticidal activities against
neonate larvae of S. littoralis, the lipophilic extracts of the roots
of S. curtisii and S. cochinchinensis displayed very strong activi-
ties while weaker activities were found for S. kerrii and Stemona
sp. HG915. The insecticidal activities of 13 Stemona alkaloids
were compared, and 16,17-didehydro-16(E)-stemofoline (70) was
shown to be the most toxic, followed by stemofoline,4 oxy-
stemokerrin (87) and dehydroprotostemonine (25) (LC50 < 10
ppm).19
The larvicidal activity of the crude root extract of S. curtisii,
and its three main alkaloid components [stemocurtisine (77),
stemocurtisinol (86) and oxyprotostemonine (26)] was investi-
gated against the mosquito larvae of Anopheles minimus. The
isolated alkaloids were significantly more active than the crude
extract. Among them, oxyprotostemonine (26) was the most
potent (LC50 ¼ 4 ppm).39
The insecticidal activity of 6b-hydroxystemofoline (74), 16-
hydroxystemofoline (75), neostemofoline (27), protostemodiol
(61) and 13-demethoxy-(11S*,12R*)-dihydroprotostemonine
(22), isolated from the stems and leaves of S. japonica, was
determined by electrophysiological in vitro tests on the nicotinic
acetylcholine receptor (nAchR) of Heliothis virescens. Alkaloids
74, 75 and 27 acted as in vitro agonists for the pest insect whereas
alkaloids 61 and 22 showed antagonist effect. 16-Hydroxy-
stemofoline (75) displayed lower activity then stemofoline4 in an
in vivo screen, while 6b-hydroxystemofoline (74) was inactive at
the application rate described.20
Sessilistemonamines A–C (48–50), isolated from S. sessilifolia,




























































View Article Onlineproperties. Alkaloids 48 and 49 were moderately active but much
less than huperzine A, used as positive control.24
The crude CH2Cl2 extract of S. aphylla and stemaphylline (57)
were screened for their AchE-inhibition properties by TLC bio-
autography. The results showed that the crude extract had higher
activity than 57, which was assigned to the presence of stemo-
foline4 in the extract. Additionally, both samples displayed very
weak antimicrobial (Gram-negative and Gram-positive bacteria)
and antifungal activities.29
Isooxymaistemonine (51) and isomaistemonine (52), isolated
from S. sessilifolia, were assayed for transcriptional regulation of
human high-density lipoprotein (HDL) receptor gene CD36 and
LIMP II analogous-1 (CLA-1). Alkaloid 52 displayed a positive
effect and it was suggested as a new therapeutic target for athero-
sclerosis. A weak up-regulation was observed for alkaloid 52.22
5 Synthetic sources
5.1 Stenine group
In the period covered by this review, Morimoto and coworkers
disclosed the full account of their total synthesis of ()-stenine
(1),57 the earlier communication having appeared in 1996, and
thus included in our previous review.4
Wipf and Spencer58 have developed an approach to the
synthesis of tuberostemonine (Scheme 1) which consisted of the
oxidative cyclization of Cbz-L-tyrosine (105) in nitromethane to
provide hydroindole derivative 107, after O-benzoylation of the
corresponding alcohol. A series of high-yielding chemicalScheme 1 Reagents and conditions: (a) PhI(OAc)2, MeNO2 (0.3 M), 2.5 h (3
(97%); (e) Pd2(dba)3CHCl3 (2 mol%), PBn3 (8 mol%), Et3N, HCO2H, THF, refl
(h) cinnamyl bromide, K2CO3 (96%); (i)TBAF, THF (96%); (j) TPAP, NMO (
Et3N (91%); (n) (PPh3)3RhCl, H2; (o) DBU, CH2Cl2 (89%, two steps); (p)
HN(OMe)Me (94%); (s) 112 (95%); (t) L-Selectride (80%); (u) p-TsOH, MeOH
(w) PhSeCl, MeCN–H2O (67%); (x) AllylSnPh3, AIBN, THF, (70%) (y) MeI, L
(85%); (a1) p-TsOH; (b1) 117, ethylene, CH2Cl2, reflux (81%, two steps); (c1)
1922 | Nat. Prod. Rep., 2010, 27, 1908–1937transformations converted 107 to hydroindole 108 which
underwent N-alkylation with cinnamyl bromide, followed by
introduction of the allyl side chain to provide 109. Ring-closing
metathesis allowed the formation of the azepine ring, which had
its double bond reduced over three steps. The installation of the
g-butyrolactone ring at C-3 required the addition of the lithium
anion 112 to the intermediate Weinreb amide and provided
ketone 113, which was reduced with L-Selectride, followed by
acid treatment, to provide intermediate 114. Allylic alcohol 114
was subjected to an Eschenmoser–Claisen rearrangement with
N,N-dimethylacetamide dimethylacetal, followed by seleno-
lactonization, to provide 115 which underwent Keck allylation,
followed by stereoselective a-methylation to give 116. Double
bond isomerization was promoted by catalyst 110 and set the
stage for the intermolecular metathesis with ethylene after
conversion to the corresponding tosylate salt. Catalytic hydro-
genation of the double bond then led to the completion of the
first total synthesis of tuberostemonine (29 steps and ca. 0.2%
overall yield) which was converted to didehydrotuberostemonine
by treatment with silver(II) oxide.
Aube and coworkers59 successfully carried out the total
syntheses of ()-stenine (1) and ()-neostenine (3; also known as
isostenine), via a tandem Diels–Alder/azido-Schmidt reaction
sequence (Scheme 2). A first-generation approach was developed
starting with diene 118, obtained from 1,5-pentanediol, which
was converted to ketophosphonate 119. Horner–Wadsworth–
Emmons olefination of 3-azidopropanal with 119 provided the
key azido triene 120 which was treated with 1 equiv. of MeAlCl25%); (b) Na2CO3, MeOH; (c) Bz2O, pyr (51%); (d) NaBH4, CeCl3$7H2O
ux (93%); (f) TBSCl, imidazole (97%); (g) Et3SiH, Pd(OAc)2, Et3N (90%);
88%); (k) KHMDS, allyl iodide (66%); (l) 110 (5 mol%) (92%); (m) PhSH,
NaBH4, CeCl3$7H2O (71%); (q) TBSCl, imidazole (79%); (r) Me2AlCl,
(70%); (v) N,N-dimethylacetamide dimethylacetal, xylenes, reflux (78%);
DA, THF–HMPA (59%); (z) 110, allyltritylamine, DIEA, CH2Cl2, reflux
H2, Pd/C, MeOH (97%).




























































View Article Onlinein CH2Cl2 at room temperature to undergo the key Diels–
Alder – azido-Schmidt reaction to provide tricyclic amide 121 in
an endo fashion. Iodolactonization and allylation, followed by
stereoselective methylation at C-13, gave intermediate 122, thus
providing a formal synthesis of ()-stenine (1).
Another approach to ()-stenine (1) was devised based on
a tandem intermolecular Diels–Alder/intramolecular Schmidt
reaction (Scheme 3).59,60 Olefination of 3-azidopropanal with
known Horner–Wadsworth–Emmons reagent 123 provided the
corresponding enone which was converted to silyloxy diene 124.
Exo-selective intermolecular Diels–Alder reaction between diene
124 and cyclohexenone with SnCl4 catalysis provided tricylic
lactams 125 and 126 as a 3 : 1 mixture (endo-selective Diels–
Alder reaction).
Alkylation of lactam 125, followed by stereoselective NaBH4
carbonyl reduction, provided tetracyclic lactam 128 which had its
structure established by X-ray diffraction analysis and was
straightforwardly converted to ()-stenine (1), after treatment
with Lawesson’s reagent and reduction with Raney nickel. This
approach provided ()-stenine (1) in 8 steps and 14% overall
yield from dimethyl methylphosphonate.
The endo-selective intermolecular Diels–Alder – Schmidt
reaction described above proved to be of potential utility for the
preparation of ()-neostenine (Scheme 4), also known as iso-
stenine (3). In fact, the desired endo stereochemistry could beScheme 2 Reagents and conditions: (a) PPTS, EtOH; (b) (COCl)2, DMSO
Ba(OH)2$8H2O, N3(CH2)2CHO (85%); (f) MeAlCl2 (1.0 equiv), CH2Cl2, 45
steps); (j) Bu3SnCH]CHCH2, AIBN, benzene; (k) LiHMDS, MeI (67%, tw
Scheme 3 Reagents and conditions: (a) NaH, N3(CH2)2CHO; (b) TMSOT
BrCH2CO2Et (73%); (e) NaBH4 (64%); (f) LiHMDS; MeI (79%) (g) Lawesso
This journal is ª The Royal Society of Chemistry 2010achieved when diene 130 reacted with 2-cyclohexenone and
BF3$OEt2 (3.0 equiv.) as the Lewis acid. Under these experi-
mental conditions, a mixture of epimers at C-10 (131a + 131b)
was obtained (with the a isomer as the major isomer), together
with bicylic azido diketone 132, which could be converted to the
mixture of 131a and 131b upon treatment with TiCl4.
The mixture of tricyclic lactams 131a and 131b readily
converged to the thermodynamically favored 131 upon treatment
with MeONa in methanol. Regio- and stereoselective alkylation
of 131 with ethyl bromoacetate provided ketoester 133 which was
reduced to the corresponding alcohol upon treatment with
a combination of CeCl3 and L-Selectride to provide a mixture of
tetracyclic lactone 135 and lactol 134 which was oxidized with
TPAP/NMO to provide 135 as a single lactone. The protocol
developed by Greene was employed in order to establish the a-
methylene moiety in 136 as a handle to introduce the C-13 methyl
group with the correct configuration. Treatment of the lithium
enolate of 135 with CO2 provided the corresponding a-carboxylic
acid which was subjected to condensation with formaldehyde,
followed by decarboxylation to provide a-methylene butyr-
olactone 136. The total synthesis of ()-neostenine was achieved
in 11 steps and ca. 11% overall yield from commercially available
starting materials, after hydrogenation of 136 with Adams
catalyst in methanol–acetic acid (1 : 1 mixture), conversion to the
corresponding thiolactam and Raney nickel reduction., Et3N; (c) (MeO)2P(O)CH2Li; (d) TPAP, NMO (65%, four steps); (e)
C (43%); (g) Na, NH3 (l); (h) CrO3, H2SO4; (i) I2, NaHCO3 (80%, three
o steps).
f (87%, two steps); (c) 2-cyclohexenone, SnCl4 (70%); (d) LiHMDS,
n’s reagent; (h) Raney Ni (83%, two steps).
Nat. Prod. Rep., 2010, 27, 1908–1937 | 1923
Scheme 4 Reagents and conditions: (a) 2-cyclohexenone, BF3$OEt2, 78 C to 30 C; (b) TiCl4, CH2Cl2 (55%, two steps); (c) MeOH, MeONa (83%);
(d) LiHMDS, BrCH2CO2Et (95%); (e) CeCl3, L-Selectride (77%); (f) TPAP, NMO (83%); (g) LiHMDS; CO2 (g); (h) H2CO, PhNHMe, AcOH, NaOAc
(49%, two steps) (i) H2, PtO2, MeOH:AcOH (91%); (j) P2S10; (k) Raney




























































View Article OnlineA protecting-group-free total synthesis of ()-neostenine
(Scheme 5) was described by Booker-Milburn and coworkers,61
based on the [5 + 2] photocycloaddition of maleimides which led
directly to the pyrrolo[1,2-a]azepine moiety characteristic of the
Stemona alkaloids. Multigram quantities of diol ()-139 were
secured via the Diels–Alder reaction involving furan (137) and
fumaryl chloride (138), followed by reduction with LiAlH4 (72%
overall yield). Bislactone 140 underwent SN2
0 ring-opening uponScheme 5 Reagents and conditions: (a) THF, 0 C; then LiAlH4, 0
C to rt (7
KOH, H2O, 100
C (93%); (d) p-TSA, toluene, reflux (93%) or (e) H2SO4 (6
Et3N; then NaBH4 (81%); (h) 3,4-dichloromaleimide, Ph3P, DEAD, THF (7
AcOH (95%); (k) LiAl(OtBu)3H, THF, 0
C (99%); (l) PhOCSCl, DMAP,
LiHMDS, THF, MeI, 78 C; then BHT, THF (67%, 5 : 1 mixture); (p) 5%
1924 | Nat. Prod. Rep., 2010, 27, 1908–1937treatment with EtMgCl in the presence of CuBr$Me2S to afford
carboxylic acid 141 as a 15.6 : 1 mixture with its epimer at C-10
(neostenine numbering). Selective reduction of the carboxylic
functionality in 141, followed by coupling with 3,4-dichloro-
maleimide under Mitsunobu conditions, provided maleimide 142
which was converted to the desired photocycloadduct 143 in
moderate yield when irradiated in a Pyrex immersion well pho-
toreactor (125 W medium-pressure Hg lamp) on a 50 mg scale.2%); (b) MsCl, Et3N, THF, 25
C; then KCN, DMSO, 100 C (84%); (c)
M), 100 C (45%); (f) EtMgCl, CuBr$Me2S, THF (94%); (g) EtOCOCl,
1%); (i) hv, 400 W Hg lamp, Pyrex photoreactor, CH2Cl2 (63%); (j) Zn,
CH2Cl2, reflux (67%); (m) Bu3SnH, AIBN, benzene, reflux (94%); (n)
RhH(CO)(PPh3)3, Ph2SiH2, THF (69%).
This journal is ª The Royal Society of Chemistry 2010
Scheme 6 Reagents and conditions: (a) LDA, THF, (MeS)2CHCHO; (b) Ac2O (80%, 4 : 1 mixture); (c) (E)-MeO2CCH2CHCHCH2COCl, CH2Cl2
(85%, 4 : 1 mixture); (d) DMTSF, CH3CN, 40
C; then Et3N (87%); (e) Raney
 Ni, EtOH (95%); (f) NaBH4, CeCl3$7H2O, MeOH (77%) (g) H2, CH2Cl2,
Crabtree’s catalyst (80%); (h) MsCl, Et3N, DBU; then DBU, toluene, reflux (64%); (i) LiOH, THF, H2O; then I2, MeCN (60%); (j) CH2]CHCH2SnBu3,
AIBN (62%); (k) OsO4, NaIO4, THF–H2O; (l) HSCH2CH2SH, BF3$OEt2 (50%%, two steps); (m) Lawesson’s reagent (77%); (n) Raney
 Ni, EtOH




























































View Article OnlineHowever, the yield dropped significantly when scaled up to >100
mg batches, and it required the development of a novel flow
reactor for continuous photochemical synthesis in order to
achieve the preparation of 143 in 63% yield (with recovery of 20%
of starting material) upon irradiation of a 103 M solution of 142
with a 400 W Hg lamp in a 15-loop reactor.
With a reliable route to 143 secured, it was uneventfully con-
verted to 144 which underwent methylation with LHMDS/CH3I
to provide a 7 : 1 mixture of epimers in favor of the unnatural
isomer at C-13 (neostenine numbering). Epimerization via eno-
lization and protonation with BHT (2,6-di-tert-butyl-4-methyl-
phenol) provided a 5 : 1 mixture of the a- and b-epimers. Purified
a-epimer was successfully reduced to ()-neostenine in 69% yield
upon treatment with RhH(CO)(PPh3)3/Ph2SiH2. The total
synthesis of ()-neostenine was achieved in 12 steps and 2%
overall yield from 137 and 138.
Padwa and Ginn62 developed an approach to the synthesis of
()-stenine (1) (Scheme 6) based on a combined intramolecular
[4 + 2] cycloaddition–rearrangement cascade to access the
tricyclic lactam core of ()-stenine (1). Starting from 3-capro-
lactam, the lithium enolate of the corresponding N-trimethylsilyl
derivative 145 was treated with 2,2-bis(methylsulfanyl)acetalde-
hyde, followed by acetylation, to provide 146 in 80% yield as
a 4 : 1 mixture of stereoisomers which was converted to lactam
147 upon treatment with but-3-enoyl chloride (85% yield, 4 : 1
mixture). Dimethyl(methylthio)sulfonium tetrafluoroborate
(DMTSF)-induced reaction of dithioketal 147 in acetonitrile,
followed by treatment with triethylamine, provided rapidly epi-
merizable tricyclic lactam 148, in 87% yield, via a [4 + 2]
combined cycloaddition–rearrangement pathway. Removal of
the thiomethyl group with Raney nickel was followed by
reduction under Luche’s conditions to provide the corresponding
alcohol which had its structure unambiguously established by
X-ray analysis. Hydrogenation of the enamido double bond with
Crabtree’s catalyst, followed by mesylation, led to saturatedThis journal is ª The Royal Society of Chemistry 2010tricyclic lactam 149. Iodolactonization followed by allylation
reaction afforded lactone 150. Oxidative cleavage and trapping
of the intermediate aldehyde as the cyclic dithiane 151 paved the
way for its conversion to the corresponding thiolactam. Reduc-
tive treatment with Raney nickel and stereoselective methyla-
tion at C-13 provided ()-stenine (1) in ca. 1% yield from
3-caprolactam, after 15 steps.5.2 Stemoamide group
During the period of this review, the total synthesis of stemoa-
mide (15), structurally the simplest member of the Stemona class
containing a tricyclic core and four contiguous stereogenic
centers, continued to receive much attention either in the context
of a more general strategy to the Stemona family of alkaloids or
as a proof of concept for novel methodologies. Since the 7-step
synthesis by Jacobi and coworkers,63,64 many authors have devised
novel approaches to enantiomerically pure stemoamide (15).
A formal synthesis of ()-stemoamide (15) from allofuranose
152, prepared from D-glucose diacetonide in three steps, was
described by Gurjar and Reddy,65 and featured the creation of
the stereogenic center at C-9a via a stereoselective zinc-mediated
allylation (Scheme 7). The construction of the pyrrolidinone
ring was then achieved via introduction of the azido functionality
and oxidation of the unsaturated side chain in 153. The seven-
membered azepino ring was installed after a ring-closing
metathesis reaction, and the hydroxyl group present in 157 was
removed under Barton–McCombie conditions. g-Lactone 158,
the precursor of ()-stemoamide (15), was then prepared by
oxidation with MCPBA and BF3$OEt2.
The first total synthesis of ()-stemonine was reported by
Williams and coworkers (Scheme 8)66 through sequential ring-
closure reactions involving intramolecular aza-Wittig and iodo-
cyclization reactions. The synthesis of ()-stemonine was carried
out in 24 steps (longest linear sequence) from 159 with an overallNat. Prod. Rep., 2010, 27, 1908–1937 | 1925
Scheme 7 Reagents and conditions: (a) (COCl)2, DMSO, Et3N, 78 C (80%); (b) allyl bromide, Zn, satd. NH4Cl, THF or (CH2]CHCH2)2Zn, THF,
Et2O, 78 C (81%); (c) BH3$Me2S, THF, 0 C to rt, then NaOAc, H2O2 (65%); (d) TBSCl, imidazole, CH2Cl2, rt (90%); (e) MsCl, Et3N, CH2Cl2, 0 C
to rt (85%); (f) NaN3, DMF, 75–85
C (77%); (g) NaClO2, DMSO, NaH2PO4, H2O, 0
C to rt (95%); (h) CH2N2, 50% aq. KOH, Et2O,20 C (94%); (i)
10% Pd/C, H2, MeOH, rt (87%); (j) allyl bromide, 50% aq. KOH, C6H6, TBAI, rt (74%); (k) 0.8% H2SO4, MeOH, rt (84%); (l) MsCl, Et3N, CH2Cl2, 0
C
(70%); (m) NaI, ethyl methyl ketone, reflux (66%); (n) Grubbs’ catalyst, CH2Cl2, reflux (83%); (o) 10% Pd/C, H2, MeOH, rt (85%); (p) Amberlyst-15,
MeOH, reflux (70%); (q) Im2CS, toluene, reflux; (r) n-Bu3SnH, AIBN, toluene, reflux (45%, two steps); (s) MCPBA, BF3$OEt2, CH2Cl2, 0




























































View Article Onlineyield of 1%, and it features a very efficient construction of the
perhydroazepine and g-butyrolactone rings via iodine-induced
cyclization with the formation of an aziridinium intermediate
which is opened by the carboxymethyl group.
The total synthesis of ()-stemoamide (15) by Sibi and
Subramanian67 started with pyroglutamic acid (172) which was
converted to the tert-butyldimethylsilyl ether 173 (Scheme 9).Scheme 8 Reagents and conditions: (a) NaCN, DMSO, 70 C; (b) DIBAL, E
Et2O, 78 C; then 160; (d) TBAF, THF, 0 C to rt; (e) PPh3, I2, imidazole,
collidine,78 C to rt (86%); (i) LiEt3BH, THF,78 C to rt (94% yield, anti:s
(3 equiv.), HMPA, rt (65%); (l) TBSOTf, collidine, 78 C (97%); (m) Me2BB
CH2Cl2, rt (o) NaClO2, NaH2PO4, t-BuOH, CH3CN, 2-methyl-2-butene, 0
C
(56%); (r) Dess–Martin periodinane, NaHCO3, CH2Cl2, rt (86%); (s) EtPPh2, b
(v) TBAF, THF, rt (77%); (w) Dess–Martin periodinane, NaHCO3, CH2Cl2,
1926 | Nat. Prod. Rep., 2010, 27, 1908–1937N-Alkylation with 4-bromo-1-butene and chain extension via
a Wittig reaction set the stage for the key stereoselective addition
of vinyl copper reagent, which stereoselectively afforded 175 with
the opposite configuration at C-9 required for ()-stemoamide
(15). Ring-closing metathesis with a Grubbs-type catalyst pro-
ceeded with excellent yield to provide 176 after basic hydrolysis.
After iodocyclization, dehalogenation under radical conditionst2O, 78 C to rt, then H3O+ (86%); (c) TBSO(CH2)3PPh3Br, KHMDS,
CH2Cl2 (80%); (f) t-BuLi, 78 C; (g) 164, Et2O, 78 C; (h) TBSOTf,
yn¼ 17 : 1); (j) MsCl, pyridine, rt (95%); (k) NaN3 (3 equiv.), 15-crown-3
r, CH2Cl2, Et3N, 78 C (76%); (n) Dess–Martin periodinane, NaHCO3,
; (p) CH2N2, Et2O (83%, three steps); (q) DDQ, CH2Cl2, t-BuOH, H2O, rt
enzene, rt; (t) NaBH4, THF, MeOH (70%); (u) I2, CH2Cl2, Et2O, rt (42%);
rt (69%); (x) aq. CrO3, H2SO4, acetone, THF, rt (68%).
This journal is ª The Royal Society of Chemistry 2010
Scheme 9 Reagents and conditions: (a) SOCl2, MeOH; (b) NaBH4; (c) TBSCl (92%); (d) NaH, 4-bromo-1-butene (80%); (e) TBAF (95%); (f) Swern
oxidation; (g) Ph3P]CHCO2Me (73%, two steps); (h) CH2]CHMgBr, CuBr$DMS, LiBr,78 C (81%); (i) Grubbs’ 2nd-generation catalyst (6 mol%),
CH2Cl2, reflux (95%); (j) 1 N NaOH, MeOH (83%); (k) 5% NaHCO3, I2, (91%); (l) nBu3SnH, AIBN, toluene (70%); (m) LiHMDS, PhSeBr (81%); (n)
H2O2 (76%); (o) NaBH4, NiCl2 (78%); (p) LiHMDS, MeI, THF (70%).
Scheme 10 Reagents and conditions: (a) TiCl4, iPr2NEt, CH2Cl2,78 C
(92%); (b) PhCHCH2CHO, MgBr2$OEt2 (cat.), rt, TMSCl, Et3N,
EtOAc; then HCl (74%); (c) TESOTf, 2,6-lutidine, CH2Cl2, 0
C (99%);
(d) NaBH4, EtOH, 50 C (96%); (e) TPAP, NMO, CH2Cl2 (90%); (f)
Ph3P]CHOCH3, THF, 78 C (76%); (g) p-TsOH, THF–H2O, reflux
(88%); (h) PCC, NaOAc (87%); (i) 185, ClCH2CH2Cl, reflux (60%); (j)




























































View Article Onlineprovided the key tricyclic lactam 177 in good yield. The final
steps involved epimerization at C-9 (via selenoxide elimination
and stereoselective reduction of the double bond), and methyl-
ation at C-10 via a modification of the Narasaka procedure.
()-Stemoamide (15) was ultimately obtained after 16 steps from
(S)-pyroglutamic acid (172) and in ca. 7% overall yield
(Scheme 9).
Olivo and coworkers68 have explored the diastereoselective
addition of the titanium(IV) enolate derived from N-acetyl-4R-
isopropylthiazolidinethione (179) to the in situ generated N-
acyliminium ion derived from 5-acetoxypyrrolidinone 180 to
access the desired stereochemistry at C-9a of ()-stemoamide
(15) (Scheme 10). 5-Substituted pyrrolidinone 181 underwent
a highly diastereoselective anti-aldol reaction with cinnamalde-
hyde upon treatment with catalytic MgBr2$OEt2 in the presence
of TMSCl/Et3N, to provide aldol product 182, which was con-
verted to the corresponding triethylsilyl ether.
Ring-closing metathesis of functionalized intermediate 184
afforded, after hydrogenation and a-methylation, ()-stemoamide
(15) in 12 steps and 14% overall yield from thiazolidinethione 179
and 5-acetoxypyrrolidinone 180.
Somfai and coworkers69 carried out the total synthesis of
()-stemoamide (15) (Scheme 11) with the formation of the g-
butyrolactone at a late stage of the synthesis via stereoselective
bromolactonization reaction of an unsaturated azepine which
was put into place via a ring-closing metathesis reaction of 189,
a 5-substituted-N-alkenyl derivative of (S)-pyroglutamic acid,
under high dilution conditions.
Attempts to install the C-8 hydroxyl group along with the
correct C-8–C-9 trans stereochemistry via hydroboration failed,
and the unsaturated g-butyrolactone 191 displaying the C-8 b-
configuration was eventually prepared via bromolactonization
reaction, after basic hydrolysis and treatment with CuBr2 on
alumina. The trans stereochemistry at C-8–C-9 was secured via
NaBH4/NiCl2$6H2O stereoselective reduction followed by ster-
eoselective methylation, to provide ()-stemoamide (15) in 12
steps and 20% overall yield from alcohol 186.
Bates and Sridhar developed a total synthesis of ()-stemoa-
mide (15) (Scheme 12) based on the intramolecular propargylic
Barbier reaction to construct the azepine ring.70 Sulfinate 194,
prepared from succinimide (192), underwent displacement withThis journal is ª The Royal Society of Chemistry 2010a protected propargylic acetylide under Lewis acid treatment to
afford 195. A series of functional group interconversion set the
stage for the intramolecular Barbier reaction, which provided
allenol 196 (16 : 1 diastereoisomeric ratio), when indium was
employed in wet THF in the presence of acetic acid. The
synthesis was completed by cyclocarbonylation of allenol 196,
employing triruthenium dodecarbonyl as catalyst in the presenceNat. Prod. Rep., 2010, 27, 1908–1937 | 1927
Scheme 11 Reagents and conditions: (a) TBSCl, imidazole, CH2Cl2, rt
(98%); (b) Br(CH2)3CH]CH2, NaHMDS, DMF, 15 C; (c) TBAF,
THF, 0 C (92%, two steps); (d) Swern oxidation; (e) (MeO)2-
P(O)C(N2)COMe, K2CO3, MeOH, rt (92%, two steps); (f) B-iodo-9-
BBN, CH2Cl2–hexane, 20 C (72%); (g) BrZnCH2CO2Et, Pd(PPh3)4,
THF–DMPU, 50 C (78%); (h) Grubbs’ 2nd-generation catalyst,
CH2Cl2, reflux (92%); (i) LiOH$H2O, THF–MeOH, H2O; (j) CuBr2 on
Al2O3, CHCl3, 65
C, then Et3N, rt (65%, two steps); (k) NiCl2, NaBH4,
MeOH, 30 C (90%); (l) MeI, THF, LHMDS, 78 C (78%).
Scheme 12 Reagents and conditions: (a) NaBH4, EtOH, 5 C; (b) HCl
(60%, two steps); (c) nBuLi, THF; Br(CH2)2CH2CH(OCH2)2, DMSO
(92%); (d) PhSO2H (99%); (e) THPCH2CCMgCl, ZnBr2(72%); (f) PS-
PPTS, MeOH; (g) MsCl, Et3N; (h) LiBr, THF; (i) TsOH, acetone, H2O
(42%, four steps); (j) In, AcOH, THF, H2O (82%, dr ¼ 16 : 1); (k)
Ru3(CO)12, Et3N, CO (100 psi), 100





























































View Article Onlineof triethylamine under 100 psi of carbon monoxide, followed by
reduction of butenolide 197, to afford ()-stemoamide (15) in 12
steps and 6% overall yield from succinimide (192).
Cossy and coworkers71 have developed two approaches to
formal syntheses of stemoamide (15). The first one (Scheme 13)
was based on a sequential reductive desymmetrization–lactoni-
zation–reduction reaction of 1,3-dicarbonylic esters 199 and 200
prepared from 2,4-pentanedione (198). Hydrogen transfer reac-
tion using Noyori’s catalyst (R,R)-201 provided a 4 : 1 mixture of
g-butyrolactones 202 and 203. The optical purity of major
isomer 202 was established to be greater than 95%, and the
relative configuration at the C-8 and C-9 stereocenters was
established later in the synthesis.
Lactone 202 was converted to the corresponding azide under
Mitsunobu conditions, followed by oxidative cleavage to the
dicarboxylic acid 204, which was used in the next step without
further purification. After hydrogenolysis of the azide group and
cyclization to the corresponding pyrrolidinone 205 in refluxing
toluene, the corresponding alcohol was obtained upon treatment
with borane and converted to mesylate 206 in 10 steps and 0.7%
overall yield from 2,4-pentanedione (198). Since the racemic
form of mesylate 206 had been previously converted to ()-ste-
moamide (15) by Kohno and Narasaka,72 this approach consti-
tutes a formal synthesis of (+)-stemoamide (15).
The second approach provided a formal synthesis of ()-ste-
moamide (15) with the construction of ring A via a 5-exo-trig
radical cyclization with atom transfer73 (Scheme 14). Alcohol 2071928 | Nat. Prod. Rep., 2010, 27, 1908–1937was prepared from 2,3-dihydrofuran and it was converted to the
corresponding iodoacetate 208. The key radical cyclization was
performed in the presence of a catalytic amount of dilauryl
peroxide (DLP) in refluxing benzene to provide a equimolar
mixture of inseparable iodolactones 209 and 210. Treatment with
NaN3 in DMF at 80
C afforded an inseparable mixture of the
corresponding azides which was eventually converted to 211/212.
Removal of the protecting group under acidic conditions and
treatment with methanesulfonyl chloride afforded mesylates 206/
215 as a 1 : 1 mixture.
As mesylates 206/215 proved to be inseparable, the 1 : 1
mixture was cyclized under Narasaka’s condition (0.01 M NaH
in THF) to provide a 3 : 1 mixture of tricyclic lactam 216 and its
9a-epimer 217. As lactam 216 has been previously transformed
into ()-stemoamide (15), this reaction sequence corresponds to
the formal synthesis of the racemic form of ()-stemoamide (15).5.3 Tuberostemospironine group
The first total synthesis of stemospironine, a structurally
complex Stemona alkaloid, was accomplished by Williams and
coworkers74 (Scheme 15) using the same strategy successfully
applied in the total synthesis of croomine and stemoamide,
which features the construction of a fully functionalized acyclic
carbon chain, followed by sequential ring closures. In this
particular target, the chirality at C-11 and C-16 was designed to
come from (S)- and (R)-methyl 3-hydroxy-2-methylpropionate,
respectively.
(R)-Alpine borane reduction of propargylic ketone 218
provided the corresponding alcohol (88% ee) displaying the
stereogenic center at C-8 (stemospironine numbering). After
hydroxyl protection and acylation of the terminal acetylene,This journal is ª The Royal Society of Chemistry 2010
Scheme 14 Reagents and conditions: (a) BrCH2COBr, pyridine, CH2Cl2
(85%); (b) Grubbs’ 2nd-generation catalyst (2 mol%),
CH2]CH(CH2)2CO2Et (1.5 equiv.), CH2Cl2, 40
C (54%); (c) LiI (10
equiv.), DMF, rt (75%); (d) DLP (30 mol%), benzene, 80 C, 45 min
(65%); (e) NaN3, DMF, 80
C, 1 h; (f) H2, Pd/C, MeOH (44%, two steps,
1 : 1 mixture); (g) p-TSA (cat.), MeOH (93%); (h) MsCl, Et3N, CH2Cl2,
(89%); (i) NaH, THF, 0.01 M, 217:216 ¼ 3 : 1 (60%).
Scheme 13 Reagents and conditions: (a) NaH; sBuLi, TMEDA; then
allyl bromide, cyclohexane (34%); (b) NaH; then BrCH2CO2Et, THF
(209:210 ¼ 2.5 : 1); (c) (R,R)-201, HCO2H, Et3N, 6 days, rt (48% from
201, 202:203 ¼ 4 : 1); (d) DIAD, DPPA, PPh3, THF, 0 C; (e)
RuCl3$nH2O, NaIO4, (dr ¼ 4 : 1); (f) H2, Pd/C, MeOH; (g) 4 A MS,
toluene, 126 C, (dr¼ 4 : 1); (h) BH3$THF, THF,30 C (6% from 202);




























































View Article Onlinepropargylic ester 219 underwent stereoselective Cu(I)-catalyzed
conjugate addition of Grignard reagent to afford (E)-a,b-
unsaturated ester 220. After functional group manipulations,
allylic alcohol 221 underwent Sharpless asymmetric epoxidation
with ()-DIPT to provide a 4 : 1 mixture of stereoisomers. The
major isomer was isolated by flash silica gel chromatography and
was converted to (E)-a,b-unsaturated ester 223. Reduction to the
corresponding primary alcohol and protection as the pivalic ester
provided epoxide 224, which underwent epoxide opening with
lithium azide in DMPU with solid ammonium chloride at 130 C
to provide azido alcohol 225 in 83% yield. Exposure of the
primary alcohol and Swern oxidation led to a 3 : 1 ratio of lactols
226 and the corresponding hydroxy aldehyde. Treatment of this
equilibrating mixture with the triphenylphosphorane derived
from 227 provided exclusively Z-alkene 228. Acidic removal of
the MEM protecting group and basic hydrolysis of the benzoate
ester provided triol 229. Jones’ oxidation, followed by esterifi-
cation with diazomethane, provided lactone 230 in 80% yield
(two steps). Cleavage of the benzyl ether at low temperature
with BCl3, followed by Dess–Martin oxidation, provided the keyThis journal is ª The Royal Society of Chemistry 2010azido aldehyde intermediate for the aza-Wittig step. Upon
exposure to triphenylphosphine the corresponding aza-ylide
underwent the aza-Wittig reaction to provide a seven-membered
imine for in situ reduction with sodium borohydride. Iodine-
promoted stereoselective double cyclization of azepine 231
provided ()-stemospironine in reproducible 30% yield.
The first total synthesis of ()-stemospironine was carried out
in 24 steps and less than 1% overall yield from propargylic ketone
218, prepared in two steps from 4-benzyloxybutenal.
Stemonidine was isolated from S. tuberosa by Xu and
coworkers75 in 1982, and had its structure later revised to
structure 241. Figueredo and coworkers76 have devised a total
synthesis of the putative structure 241 and have shown that
synthetic 241 was not identical to the natural product isolated
from S. tuberosa.
1,3-Dipolar cycloaddition between nitrone 232 (prepared from
L-prolinol) and diester 233 afforded endo-isoxazolidine 234,
accompanied by the corresponding exo isomer (Scheme 16).
Reductive cleavage with Zn in glacial acetic acid, followed by
treatment with aqueous ammonia and heating, provided 235
which was converted to bicyclic lactam 236. The spiro g-methy-
lene butyrolactone moiety was introduced via treatment of 236Nat. Prod. Rep., 2010, 27, 1908–1937 | 1929
Scheme 15 Reagents and conditions: (a) (R)-Alpine borane, THF, 10 C to rt (95%, 88% ee); (b) TBDPSCl, imidazole, CH2Cl2, rt (80%); (c) nBuLi,
ClCO2iPr, THF, 78 C (90%); (d) (S)-MEMOCH2CH(CH3)CH2MgBr, CuBr$DMS, THF, 78 C to rt (70%); (e) TBAF, THF, rt (90%); (f) NaH,
MeI, DMF (85%); (g) DIBAL-H, CH2Cl2, 78 C (92%); (h) Ti(OiPr)4, CaH2, SiO2, ()-DIPT, tBuOOH, CH2Cl2, 20 C (85–90%, 4 : 1 mixture of
isomers); (i) Dess–Martin periodinane, pyridine, CH2Cl2; then Ph3PCHCO2CH3 (60%, two steps); (j) 5% Rh/Al2O3, H2, THF (85%); (k) LiBH4,
CH3OH, Et2O (90%); (l) PivCl, pyridine, DMAP (91%); (m) LiN3, NH4Cl, DMPU, 130
C (83%); (n) LiOH, THF, MeOH, H2O (94%); (o) Swern
oxidation (97%); (p) KOtBu, (S)-Ph3P
+(CH2)2CH(CH3)CH2OBz I
 (227), THF, 10 C (77%); (q) HCl, THF, rt (85%); (r) LiOH, THF, MeOH (88%);
(s) Jones’ reagent, THF, 10 C; (t) CH2N2, Et2O, 0 C (80%, two steps); (u) BCl3, CH2Cl2, 78 C to rt (60%); (v) Dess–Martin periodinane, CH2Cl2
(80%); (w) PPh3, THF; then NaBH4, MeOH, rt (60%); (x) I2, CH2Cl2, Et2O, rt (30%).
Scheme 16 Reagents and conditions: (a) (E)-MeO2CCH2CH2CH]CHCO2Me (233), toluene, reflux (78%); (b) Zn, AcOH; (c) aq. NH3; (d) toluene,
reflux (84%, three steps); (e) PPh3, DIAD, BzOH, THF (88%); (f) OsO4, NMO, acetone–H2O (92%); (g) NaH, THF; then Me2SO4 (84%); (h) LiBH4,
THF (97%); (i) Pb(OAc)4, THF (92%); (j) EtO2CC(]CH2)CH2Br, Zn, THF (86%); (k) Et3N$3HF, THF (87%); (l) Dess–Martin, CH2Cl2 (92%); (m)
EtO2CC(]CH2)CH2Br, Zn, THF (73%, 1 : 1 mixture); (n) H2 (6 bar), Pd/C, EtOH, HCl (68%); (o) Lawesson’s reagent; (p) Raney
 Ni, EtOH (45%, two
steps).





























































Scheme 17 Reagents and conditions: (a) EtC(]CH2)CH2MgCl, THF (76%); (b) tBuOOH, VO(acac)2; (c) TMSCl, imidazole, THF (66%, two steps); (d)
TiCl4, CH2Cl2,78 to 0 C (68%); (e) PCC, CH2Cl2, rt (85%); (f) O3, CH2Cl2; (g) KOtBu, tBuOH (77%, two steps); (h) LiHMDS,78 C; then HMPA,
NCCO2Me (95%); (i) CeCl3$7H2O, O2, iPrOH, rt (92%, 1 : 1 mixture of separable isomers); (j) (CH3CH2CO)2O, Et3N, DMAP, CH2Cl2, rt (95%); (k)
KOtBu, benzene, 18-crown-6; then Et3N, Me2SO4, CH2Cl2 (44%); (l) Lawesson’s reagent; (m) Raney
 Ni W2 (93%, two steps).
Scheme 18 Reagents and conditions: (a) BnO(CH2)3MgBr, Et2O, reflux; (b) PPTS, MeOH, rt (90%, two steps); (c) H2, Pd/C (90%); (d) 252, BF3$OEt2,
CH2Cl2, rt (82%); (e) (COCl)2, DMSO, Et3N, CH2Cl2; (f) DBU, CH2Cl2, rt; (g) (COCl)2, DMSO, Et3N, CH2Cl2 (70%, three steps); (h) TBDMSOTf,
collidine, toluene, 0 C to rt (80%); (i) Pd(OAc)2, O2, DMSO, 80
C (93%); (j) PMBO(CH2)4MgBr (257), 5% CuBr$Me2S, TMSCl, HMPA, THF,78 C
(74%, 6.4 : 1 mixture of 258a/258b); (k) KH, THF, then Me2N
+]CH2CF3CO2
 (76%); (l) CAN, CH3CN–H2O (80%); (m) RhCl3$xH2O, EtOH–H2O,
reflux (66%); (n) MsCl, DMAP, pyridine, CH2Cl2, 0




























































View Article Onlinewith ethyl bromomethylacrylate in the presence of zinc to
provide 237 which was straightforwardly converted to alde-
hyde 238. Treatment of 238 with ethyl bromomethylacrylate in
the presence of zinc produced a roughly 1 : 1 mixture of
bislactones 239 and 240. Hydrogenation of 240, followed by
formation of the corresponding thiolactam and desulfurization
with Raney nickel, produced a mixture of C-11 epimeric
azepines 241 and 242. Analytical samples of each isomer were
isolated by chromatography, and the structure of the less polarThis journal is ª The Royal Society of Chemistry 2010isomer was established as 241 by NMR analyses. The
13C-NMR data of both synthetic 241 and 242 did not match
those reported for stemonidine. Considering that Williams and
coworkers74 have found that the spectral and physical data of
()-stemospironine matched those reported for natural ste-
monidine, Figueredo and coworkers76 concluded that structure
241 is not correct and that the alkaloid isolated by Xu and
coworkers75 from S. tuberosa must be reassigned as stemo-
spironine.Nat. Prod. Rep., 2010, 27, 1908–1937 | 1931
Scheme 19 Reagents and conditions: (a) CH3CH2C(]CH2)CH2Cl, KOH, H2O, CuCl2 (cat.); (b) CH2CHCHO (62%, two steps); (c) NaBH(CN)3,
tBuOH–HCO2H, 35
C (75%); (d) MsCl, pyridine, CH2Cl2, rt (81%); (e) NaN3, DMF, 25
C (96%); (f) TiCl4, 0





























































View Article Online5.4 Stemonamine group
The total synthesis of ()-stemonamine (47) has been described
by Tu and coworkers77 (Scheme 17) based on a tandem semi-
pinacol rearrangement–Schmidt reaction protocol. The addition
of substituted allylmagnesium chloride to known azide 243
provided the corresponding quaternary alcohol, which was
converted to the corresponding TMS ether 244. Treatment of 244
with TiCl4 in CH2Cl2 afforded bicyclic lactam 245 as a white
solid, and this was converted to tricyclic lactam 246. The
construction of the spiro g-lactone ring involved a carboxy-
methylation reaction, followed by hydroxylation upon treatment
with CeCl3$7H2O to afford a 1 : 1 mixture of 247 and its epimer
at the quaternary carbinolic position, which were separated by
column chromatography on silica gel. Stereoisomer 247 provedScheme 20 Reagents and conditions: (a) NH2(CH2)4OTBS (266), benzene, re
H2O, rt (96%); (c) MsCl, iPr2NEt, DME, 0
C; then LiBr, rt (83%); (d) nBu3Sn
rt (76%); (f) HCCCO2Et, BuLi, THF, 78 C (271, 50%; 272, 48%); (g) Mg(
(92%); (i) (MeBO)3, PdCl2(dppf)2, Cs2CO3, dioxane, reflux (89%); (j) OsO4 (c
DIBAL, CH2Cl2, 78 C; then; MeI, rt (67%, two steps); (m) RhCl3$xH2O,
1932 | Nat. Prod. Rep., 2010, 27, 1908–1937to have the correct stereochemistry after conversion to tetracyclic
lactam 248, which was converted to the hydrochloride dihydrate
of stemonamine. The first total synthesis of ()-stemonamine
(47) was thus achieved in 13 steps and 3.7% overall yield from
known azide 243.
The first total syntheses of ()-stemonamide and ()-iso-
stemonamide were carried out by Kende and coworkers78 based
on N-acyliminium chemistry (Scheme 18). The key tricyclic
intermediates 254 (for stemonamide) and 255 (for iso-
stemonamide) were rapidly constructed via the addition of sily-
loxyfuran 252 to N-acyliminium ion precursor 251, prepared in
three steps and 81% overall yield from N-p-methoxy-
benzylsuccinimide (249). The resulting mixture of diastereoiso-
meric alcohols 253 (1 : 2 mixture) underwent oxidation to the
corresponding aldehydes under Swern conditions which wereflux; then ClCOCHCH2, Et2NPh, 0
C (35–55%); (b) p-TsOH, acetone,
H, ACN, toluene, reflux (55%, 1 : 1 mixture); (e) PhCHO, KOH, MeOH,
OMe)2, NaOMe (cat), MeOH, reflux (85%); (h) NIS, TfOH, CH2Cl2, rt
at), NaIO4, acetone–H2O (88%); (k) CH(NMe2)2OtBu, DMF, 100
C; (l)
EtOH–H2O, reflux [()-stemonamide, 31%; 278, 63%].
This journal is ª The Royal Society of Chemistry 2010
Scheme 21 Reagents and conditions: (a) Mg(OMe)2, NaOMe (cat.) MeOH, reflux (75%); (b) 280, TfOH, CH2Cl2, rt (84%); (c) (MeBO)3, PdCl2(dppf)2,
Cs2CO3, dioxane, reflux (89%); (d) OsO4 (cat.), NaIO4, tBuOH–H2O (62%); (e) CH(NMe2)2OtBu, DMF, 100
C; (f) DIBAL, CH2Cl2, 78 C; then;
MeI, rt (74%%, two steps); (g) RhCl3$xH2O, EtOH–H2O, reflux (100%); (h) Lawesson’s reagent, toluene, reflux; (i) Raney
 Ni W2, EtOH, rt (77%, two
steps).
Scheme 22 Reagents and conditions: (a) Lawesson’s reagent, toluene,




























































View Article Onlineused in the DBU-mediated aldol spirocyclization to afford
tricyclic ketones 254 and 255 as a 1 : 1 mixture readily separated
by column chromatography.
Saegusa oxidation of ketone 254 provided a,b-unsaturated
ketone 256 in 93% yield, which underwent Cu(I)-catalyzed
conjugated addition of Grignard reagent 257 carrying the four-
carbon segment necessary for the construction of the azepine ring
(Scheme 18). The major isomer 258a underwent a Mannich
reaction to introduce the exocyclic double bond in 259 (67%
yield). After removal of both PMB groups with cerium(IV)
ammonium nitrate, isomerization of the double bond was ach-
ieved in 66% yield. Alcohol 260 was uneventfully transformed to
()-stemonamide after mesylation and intramolecular displace-
ment (33% yield, two steps). ()-Isostemonamide was prepared
from 255 along similar steps as described above for ()-stemo-
namide in 8 steps and 10% overall yield from 255.
Recently, Tu and coworkers79 reported an alternative strategy
based on intramolecular Schmidt reaction which led to the
formal synthesis of ()-stemonamine (47) (Scheme 19). In the
event, allylation of 1,3-cyclohexanedione (261), followed by
Michael addition with acrolein, provided dione 262. Aldehyde
reduction, followed by mesylation and azide substitution, led to
azide 263. Treatment of azide 263 with TiCl4 in CH2Cl2 at 0
C
efficiently provided pyrrolo[1,2-a]azepine 264, which could be
converted to tricyclic lactam 246. Preparation of ()-stemon-
amine (47) was secured from 246 by the procedure described
before (Scheme 17).
Ishibashi and coworkers80,81 have developed a radical-cascade
approach to stemonamide, isostemonamide, stemonamine (47)
and isostemonamine (Schemes 20 and 21). Condensation of 1,2-
cyclopentanedione (265) with 4-(tert-butyldimethylsilyloxy)-
butylamine (266), followed by acylation with acryloyl chloride
and removal of the TBS group provided alcohol 267, which was
converted to the corresponding bromide 268 (Scheme 20).
Radical-cascade cyclization of 268 with tri-n-butyltin hydride in
the presence of 1,10-azobiscyclohexane carbonitrile (ACN)
afforded a 1 : 1 mixture of tricyclic lactams 269 and 270. The
mixture was subjected to aldol reaction with benzaldehyde toThis journal is ª The Royal Society of Chemistry 2010yield an inseparable mixture of the corresponding a,b-unsatu-
rated ketones, which underwent nucleophilic addition of lithium
ethyl propiolate from the convex face to afford adducts 271 and
272, the structures of which were established by X-ray crystal-
lographic analyses.
Treatment of acetylenic alcohol 271 with magnesium meth-
oxide in boiling methanol afforded methyl tetronate 273, which
was converted to iodide 274, followed by Suzuki–Miyaura
coupling reaction to afford 275. Oxidative cleavage of the
exocyclic double bond afforded ketone 276 which underwent a-
methylenation with Bredereck’s reagent, followed by DIBAL
reduction. Finally, isomerization of the a-methylene ketone
mediated by RhCl3 provided ()-stemonamide, together with the
saturated derivative 278 that seemed to have a b-oriented methyl
group.
Similarly, treatment of acetylenic alcohol 272 (Scheme 21) with
magnesium methoxide in refluxing methanol provided unsatu-
rated lactone 279, which was subjected to iodination followed by
Suzuki–Miyaura coupling with trimethylboroxine and catalysis
by PdCl2(dppf)2 to afford 281. Oxidative cleavage of the exocy-
clic double bond, followed by treatment with Bredereck’s reagent
and DIBAL reduction, provided a,b-unsaturated ketone 282,
which was converted to ()-isostemonamide quantitatively after
double-bond isomerization.
()-Isostemonamine and ()-stemonamine (47) were obtained
from ()-isostemonamide and ()-stemonamide (Schemes 21
and 22), respectively, upon treatment with Lawesson’s reagent,Nat. Prod. Rep., 2010, 27, 1908–1937 | 1933
Scheme 23 Reagents and conditions: (a) Na2S2O4, EtOH, H2O, 90
C (35%); (b) (Boc)2O, DMAP, CH3CN (72%); (c) 285, rhodium octanoate dimer,
pentane, reflux (90%); (d) Bu4NF, THF (65%); (e) H2, Pd/C, MeOH (90%); (f) H2O, DMSO, 150
C (90%); (g) furfuraldehyde, NaOH, MeOH, H2O
(90%); (h) LiHMDS, DMPU, THF, 0 C; then allyl iodide, rt (91%); (i) toluene, reflux (86%); (j) K2OsO4, NaIO4, Et2O, H2O, rt; (k) Zn(BH4)2, THF,
10 C (52%, two steps); (l) TIPSCl, imidazole, DMF (93%); (m) MeLi, DMPU, Et2O,40 C (85%); (n) Bu4NF, THF (90%); (o) TsCl, pyridine, CHCl3
(90%); (p) O3, CH2Cl2, Me2S (65%); (q) iBuOCOCl, N-methylmorpholine, THF, 0
C; (r) NaBH4, MeOH; (s) Dess–Martin periodinane, CH2Cl2 (30%,




























































View Article Onlinefollowed by reduction with Raney nickel in ethanol at low
temperature.5.5 Stemofoline group
The first total synthesis of ()-isostemofoline (76) was reported
by Kende and coworkers (Scheme 23).36 Hydrazone 283, readily
prepared from 1,2-hexanediol, underwent reductive cyclization
with sodium hydrosulfite to provide pyrrole 284, after protection
as the tert-butyl carbamate (Boc). The key bicyclic ketone 286
was assembled by a [4 + 3] cycloaddition reaction of pyrrole 284
and diazoester 285 promoted by rhodium octanoate dimer, fol-
lowed by enol silane deprotection, exo-specific hydrogenation
and nucleophilic decarboxylation. Aldol condensation between
286 and furfuraldehyde paved the way to prepare conjugated
ketone 287 which was straightforwardly converted to 288.
Conjugated addition of methylithium to 288, followed by a series
of functional group interconversions, provided carboxylic acid
289. Installation of the butenolide appendage was carried out by
addition of 290 to the aldehyde derived from 289, to afford a 2 : 1
mixture of diastereoisomeric ketones after Dess–Martin oxida-
tion Treatment with trifluoroacetic acid, followed by adjustment
to pH 10, triggered a tandem triple cyclization to provide ste-
mofoline hydrate 292. Dehydration of 292 proved surprisingly
difficult due to its propensity to undergo retroaldol reaction.
Eventually, treatment of 292 with triflic anhydride provided
a single dehydration product in low yield, which proved to be
identical by TLC and NMR analyses to isostemofoline (76). The
first total synthesis of ()-isostemofoline (76) was thus1934 | Nat. Prod. Rep., 2010, 27, 1908–1937completed in 27 steps and less than 0.1% overall yield from 1,2-
hexanediol.
The synthesis of ()-16,17-didehydro-16(E)-stemofoline (70)
and 16,17-didehydro-4(E),16(E)-stemofoline (72) by Overman
and coworkers centered on the construction of the key interme-
diate 295 by an aza-Cope–Mannich rearrangement
(Scheme 24).82
The Diels–Alder reaction between pyrrole 293 and ethyl (E)-
nitroacrylate afforded a mixture of two isomers which underwent
hydrogenation to give bicyclic nitroester 294, which had its
structure unambiguously established by X-ray diffraction anal-
ysis. After removal of the nitro group, a series of functional
group interconversions led to ketone 295. After vinyl addition
and N-Boc deprotection, the stage was set for the key tandem
iminium ion formation, [3,3]-sigmatropic rearrangement, and
Mannich cyclization which provided tricyclic ketone 296 in
nearly quantitative yield. Introduction of the (E)-butenyl side
chain and a two-carbon homologation set the stage for the
preparation of 297. The introduction of the butenolide unit was
achieved via the addition of the lithium anion of 4-methoxy-3-
methyl-2(5H)-furanone (compound 290, Scheme 23) followed by
acidic cleavage to provide the corresponding lactol, which was
oxidized to 298 upon treatment with an excess of o-iodobenzoic
acid (IBX). Condensation with thiophosgene provided a 3.5 : 1
mixture of the cyclic thiocarbonates 299 and 300, which were
converted to ()-70 and ()-72 respectively by treatment with
trimethylphosphate.
Starting with (11Z)-10,20-didehydrostemofoline (70)
(Scheme 25), isolated from the roots of an unidentified StemonaThis journal is ª The Royal Society of Chemistry 2010
Scheme 24 Reagents and conditions: (a) (E)-NO2-CH]CHCO2Et, rt; (b) H2, Pd/C, EtOAc, rt (73%, two steps); (c) DBU, CH2Cl2, rt; (d) TIPSOTf, 2,6-
lutidine, CH2Cl2; (e) DIBAL-H, toluene, 78 C (51%, three steps); (f) Dess–Martin periodinane, CH2Cl2, rt; (g) TIPSOTf, Et3N, CH2Cl2, 78 C; (h)
O3, MeOH–CH2Cl2 (72%, three steps); (i) CH2]CHMgBr, CeCl3, THF,78 C; (j) TMSI, 2,6-lutidine, 0 C to rt, MeOH (85%); (k) (CH2O)n, toluene–
CH3CN, 80
C (94%); (l) TBAF, THF, rt; (m) SO3.pyr, Et3N, DMSO, rt; (n) C7H5N4SO2nPr, KHMDS, DME, 55 C (70%, four steps); (o) LDA,
THF, ICH2CO2Et,10 C; (p) DBU, toluene, 130 C (67%, two steps); (q) BBr3, CH2Cl2,78 C to10 C; aq. NaOH; (r) TMS-imidazole, 130 C; (s)
LDA, MeI, THF–DMPU, 45 C (54%, three steps); (t) DIBAL-H, CH2Cl2, 78 C (98%); (u) Dess–Martin periodinane, rt; (v) SiO2, CHCl3, rt (54%,
three steps); (x) 290 (see Scheme 23), THF, 78 C; (y) aq. HCl, CHCl3, MeOH, rt (93%, two steps); (z) IBX, DMSO, 55 C (55%); (a1) CSCl2, DMAP,




























































View Article Onlinespecies, Pyne and coworkers83 have devised semi-syntheses of
(30R)-stemofolenol (67), (30S)-stemofolenol (68), methyl-
stemofoline (64) and (30S)-hydroxystemofoline (66).84 Selective
dihydroxylation of 70 under Sharpless conditions, followed by
diol cleavage, provided aldehyde 302. This underwent E-selective
Wittig olefination to provide a,b-unsaturated ketone 303, fol-
lowed by diastereoselective reduction with (R)- or (S)-2-meth-
yloxazaborolidine to provide (30R)- and (30S)-stemofolenol (67
and 68, respectively). Hydrogenation of (30S)-stemofolenol (68)
provided (30S)-hydroxystemofoline (66), which also could be
prepared from ketone 303 upon reduction of the carbonyl, fol-
lowed by hydrogenation of the double bond to give 66 and its C-
30epimer. The semi-synthesis of methylstemofoline (64) was
secured from aldehyde 302 after reduction to primary alcohol
304 and desulfurization of the corresponding phenylthioether
305 (formation of the corresponding E isomer was also observed)
with Raney nickel.6 Conclusion
Since our first review on the Stemona alkaloids in 2000 (which
covered the literature from 1975 to 1998), 97 additional repre-
sentatives have been described up to August 2009, revealing the
continuing interest in this family of natural compounds. During
this period, fifteen Stemonaceae species (fourteen Stemona and
one Stichoneuron species) were chemically studied.This journal is ª The Royal Society of Chemistry 2010The structural defining elements of the Stemona alkaloids have
been extended to include not only those displaying the pyr-
rolo[1,2-a]azepine core but also the pyrido[1,2-a]azepine unit. A
miscellaneous group is formed by those alkaloids which do not
display any of these structural motifs or are the sole represen-
tatives of a new group (parvineostemonine and sessilistemon-
amine D).
While some of the new representatives have had their struc-
tures unambiguously established by X-ray diffraction analyses
(neostenine, tuberostemonine J, tuberostemonine H, neo-
tuberostemonol, sessilifoliamide A, bisdehydroneostemoninine,
bisdehydrostemoninine, dihydrostemoninine, (20S)-hydroxy-
stemofoline, stemocurtisine, cochinchistemonine, stemokerrin,
stemocurtisinol, neotuberostemoninol, sessilifoliamide A and
sessilifoliamides E–J), most of them had their structures assigned
by a combination of spectroscopic and spectrometric techniques.
A few Stemona alkaloids have yielded either to total synthesis
(stenine, neostenine, stemoamide, isostemonamide, stemonamine,
isostemonamine, tuberostemonine, didehydrotuberostemonine) or
semi-synthesis ((30R)-stemofolenol, (30S)-stemofolenol, methyl-
stemofoline and (30S)-hydroxystemofoline), which leaves much
room for devising synthetic approaches for those which still do
not have their assigned structures unambiguously established, in
addition to improving the efficiency and conciseness of the
synthetic approaches to those which have already been syn-
thesised.Nat. Prod. Rep., 2010, 27, 1908–1937 | 1935
Scheme 25 Reagents and conditions: (a) AD-mix-a, MeSO2NH2, 1 : 1 tBuOH–H2O, 0
C to rt (75%); (b) NaIO4/silica gel, rt; (c) Ph3PCHC(O)CH3,
LiCl, DIPEA, CH3CN (60%, two steps); (d) (S)-2-Me-CBS-oxazaborolidine (20 mol%), BH3$Me2S, CH2Cl2, 0
C; then HO(CH2)2NH2, rt (66%); (e)
(R)-2-Me-CBS-oxazaborolidine (50 mol%), BH3$Me2S, CH2Cl2, 0
C; then HO(CH2)2NH2, rt (61%); (f) H2, Pd/C, EtOAc (57%); (g) NaBH4, MeOH
(80%); (h) PhSSPh, Bu3P, CH3CN, 5 h (305: 31% + (E)-isomer: 32%); (i) Raney




























































View Article OnlineAs to the investigation of their biological activities, studies
have covered their antitussive, insecticidal, antifeedant and
acetylcholinesterase inhibitory properties, due to the use of
herbal extracts from the Stemonaceae family for the treatment of
respiratory diseases and as antihelmintics in Asia.
Considering the pace of new Stemona alkaloids reported in the
literature in the timeframe covered by this review, the lack of
definitive proof of structure for many of them and the interest in
their biological properties, we expect interest in this family of
natural products to continue.7 Acknowledgements
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